{"study_id": 20279, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate a new fluorescence probe (HQ) for detecting and visualizing hypochlorous acid (HOCl) in rheumatoid arthritis (RA) to better understand its role in inflammatory responses.", "results_summary": "The study found that HQ effectively detected HOCl with high selectivity, sensitivity (6.5 nM), and fast response time (<25 s), while demonstrating reliability across a wide pH range (3.0\u201311.5) and low cytotoxicity. HQ successfully visualized HOCl-mediated inflammatory responses in an RA model and enabled \"naked-eye\" detection in real-world water samples.", "population_specificity": "Rheumatoid arthritis (RA) model (biological systems).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:11.315083+00:00"}
{"study_id": 20281, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare microbial changes in meibomian gland secretions before and after treatment with hypochlorous acid eyelid wipes to understand its mechanism in treating internal hordeolum.", "results_summary": "Hypochlorous acid eyelid wipes did not alter microbial biodiversity but shifted the composition, reducing pathogenic bacteria (e.g., Staphylococcus) and increasing beneficial probiotics (e.g., Faecalibacterium prausnitzii). Significant differences in microbial communities were observed at the class level after treatment.", "population_specificity": "Eight patients with internal hordeolum from an ophthalmology clinic.", "effective_dosage": "Not specified (hypochlorous acid eyelid wipes used for cleaning).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:12.317937+00:00"}
{"study_id": 20286, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "To evaluate the efficacy of hypochlorous acid (HOCl) nasal spray as an adjuvant therapy after functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis.", "results_summary": "HOCl nasal spray significantly improved endoscopic scores but not TWSNOT-22 scores, while normal saline irrigation improved TWSNOT-22 scores but not endoscopic scores. The study concluded that HOCl nasal spray had a similar effect to normal saline irrigation in post-FESS care.", "population_specificity": "Patients with chronic rhinosinusitis who had received FESS.", "effective_dosage": "0.02% HOCl nasal spray three times a day.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:18.232181+00:00"}
{"study_id": 20284, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a fluorescent probe (TPRS-HOCl) to explore the relationship between hypochlorous acid (HOCl) concentration and acute lung injury (ALI) progression, and to evaluate HOCl's inhibition effect during different treatment periods.", "results_summary": "The study found that TPRS-HOCl effectively detected HOCl levels in ALI, with imaging results aligning with H&E staining. Early treatment with N-acetylcysteine (NAC) showed better outcomes, indicating TPRS-HOCl's potential for early ALI diagnosis and treatment guidance.", "population_specificity": "Not specified (likely animal or in vitro models, given the probe development focus).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:18.559164+00:00"}
{"study_id": 20285, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether an electrochemical intravascular catheter (e-catheter) generating hypochlorous acid (HOCl) could prevent intraluminal infections in vitro.", "results_summary": "The e-catheter prototype generated a mean HOCl concentration of 15.86 \u00b1 4.03 \u03bcM and prevented infections of Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecium, and Escherichia coli, with an average reduction of 8.41 \u00b1 0.61 log10 CFU/ml at 48 h compared to controls.", "population_specificity": "Clinical isolates of bacteria derived from catheter-related infections (in vitro study).", "effective_dosage": "Continuous electrochemical generation at 1.5 VAg/AgCl (specific HOCl concentration: 15.86 \u00b1 4.03 \u03bcM).", "study_duration": "48 hours (testing period after 24 h of prepolarization).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:18.968092+00:00"}
{"study_id": 20287, "supplement_id": 1219, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the long-term clinical performance and safety of hypochlorous acid oxidising solution (AOS) when used with standard of care for hard-to-heal ulcers.", "results_summary": "By the end of the extended treatment period (224 days), 35.5% of wounds healed completely, 83.9% showed improvement, all wounds were infection-free, and pain scores decreased. The combination of AOS with standard care demonstrated a good safety profile over prolonged use.", "population_specificity": "31 patients with hard-to-heal ulcers of various aetiologies.", "effective_dosage": "Not specified", "study_duration": "32 weeks (224 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:19.917387+00:00"}
{"study_id": 20290, "supplement_id": 1219, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of hypochlorous acid (HOCl) nasal irrigation in reducing allergic rhinitis symptoms compared to saline nasal irrigation.", "results_summary": "Both HOCl and saline nasal irrigation significantly reduced allergic rhinitis symptoms, but HOCl did not show additional improvement over saline. No clinical side effects were reported with HOCl use.", "population_specificity": "139 patients with perennial allergic rhinitis (114 completed the study).", "effective_dosage": "Low-concentration HOCl (specific concentration not stated).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:20.088337+00:00"}
{"study_id": 20289, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of a hypochlorous acid (HOCl) wound management solution on MRSA reduction and wound healing compared to saline irrigation when used with debridement.", "results_summary": "The HOCl solution significantly reduced MRSA contamination (P \u2264 .05) and improved epithelialization by day 8 (78.3% vs. 67.8% for saline), but no significant differences were observed in epithelial thickness or granulation tissue formation.", "population_specificity": "Female pigs with deep reticular dermal wounds inoculated with MRSA.", "effective_dosage": "Twice daily irrigation from day 0 to day 4, then once daily until day 11.", "study_duration": "11 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:20.529186+00:00"}
{"study_id": 20288, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the antiseptic efficacy of 0.01% hypochlorous acid (HOCl) with 5% and 2.5% povidone iodine (PI) against bacterial endophthalmitis isolates on corneoscleral tissue.", "results_summary": "HOCl was less effective than both 5% and 2.5% PI in preventing bacterial growth, with statistical significance (p=0.004 and p=0.00001, respectively). For Streptococcus viridans, 5% PI was notably more effective than 2.5% PI, while HOCl was inferior to both PI concentrations.", "population_specificity": "Bacterial isolates from 20 cases of endophthalmitis, tested on donor corneoscleral tissue.", "effective_dosage": "0.01% HOCl (single application, 3-minute contact time).", "study_duration": "3-minute contact time, monitored for growth at three days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:22.224165+00:00"}
{"study_id": 20283, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the cost-effectiveness of hypochlorous acid preserved wound cleanser (HAPWOC) compared to saline as an adjunct to low-frequency ultrasound debridement for treating complex wounds.", "results_summary": "HAPWOC showed a 55% relative reduction in wound-related complications at 14 days post-debridement, with an incremental cost-effectiveness ratio of $90.85 per complication avoided. The number needed to treat (NNT) was 2, costing $99.94 per NNT.", "population_specificity": "Patients with severely complex wounds destined for primary closure via a flap.", "effective_dosage": "Not specified", "study_duration": "14 days post-debridement", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:23.482522+00:00"}
{"study_id": 20292, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the cutaneous consequences of hypochlorous acid (HOCl) exposure, including its effects on inflammatory gene expression and UV-induced carcinogenesis in skin models.", "results_summary": "The study found that HOCl suppressed UV-induced inflammatory signaling and blocked tumorigenic progression in mouse models, suggesting potential therapeutic benefits for inflammatory skin conditions.", "population_specificity": "Reconstructed human epidermis and SKH-1 hairless mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:26.013781+00:00"}
{"study_id": 20291, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antibiofilm efficacy of an electrolyzed water-based wound care solution (containing Hypochlorous Acid) against Staphylococcus aureus, Pseudomonas aeruginosa, and a multispecies biofilm in various models.", "results_summary": "The electrolyzed water-based solution demonstrated potent antibiofilm efficacy against S. aureus and, to a lesser extent, P. aeruginosa. Efficacy was reduced in the drip flow bioreactor model, likely due to nutrient flow diluting the solution.", "population_specificity": "In vitro biofilm models (S. aureus, P. aeruginosa, multispecies biofilm).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:26.791016+00:00"}
{"study_id": 20296, "supplement_id": 1219, "safety_score": "20", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of hypochlorous acid (HOCl) on human red blood cells (RBCs) under in vitro conditions, focusing on antioxidant defense, membrane integrity, and energy metabolism.", "results_summary": "HOCl treatment reduced antioxidant enzyme activity, weakened RBC antioxidant power, inhibited membrane redox systems, disrupted glucose metabolism, and caused morphological changes in RBCs, indicating increased oxidative damage susceptibility.", "population_specificity": "Human red blood cells (in vitro study)", "effective_dosage": "0.05-2.5 mM", "study_duration": "Not specified (single treatment at 37\u00b0C)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:28.894552+00:00"}
{"study_id": 20295, "supplement_id": 1219, "safety_score": "70", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the preliminary safety and performance of stabilized hypochlorous acid in acetic buffer (HOCl + buffer) for treating acute wounds.", "results_summary": "The study found that HOCl + buffer reduced bacterial load by 41% and showed excellent wound healing (96% epithelialization by days 14 and 21). Adverse events included transient pain during treatment and one wound infection.", "population_specificity": "12 subjects scheduled for split-skin graft transplantation (donor site as acute wound model).", "effective_dosage": "Treatment time of 75 seconds, administered on 6 occasions.", "study_duration": "Short-term (6 treatment occasions, follow-up to 21 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:29.118009+00:00"}
{"study_id": 20294, "supplement_id": 1219, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the antimicrobial effect and tolerability of hypochlorous acid (HA) 0.01% versus povidone-iodine (PI) 5% when applied topically to the ocular surface.", "results_summary": "Both HA and PI significantly reduced bacterial load, with HA showing a slightly greater mean reduction in CFUs. HA caused no irritation, while PI caused substantial irritation in most participants. Saline rinse after PI application increased bacterial counts in some cases.", "population_specificity": "40 patients requiring ocular antiseptic treatment.", "effective_dosage": "HA 0.01% applied topically once.", "study_duration": "1-minute exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:29.228792+00:00"}
{"study_id": 20293, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the reaction of hypochlorous acid (HOCl) with superoxide radical (O2\u2022-) as a basis for a novel non-photochemical advanced oxidation process (AOP) for degrading organic compounds.", "results_summary": "The study found that radical production was optimal at a specific ratio of [HO2\u2022/O2\u2022-] to free available chlorine (FAC), yielding significant hydroxyl radical (HO\u2022) and reactive chlorine species (RCS) exposures. Minimal direct formation of harmful byproducts like trihalomethanes (THMs) and haloacetic acids (HAAs) was observed, though their formation increased during post-chlorination.", "population_specificity": "Not specified (laboratory study with aqueous solutions and natural waters).", "effective_dosage": "Not specified (ratios and concentrations described but not exact dosages).", "study_duration": "Not specified (reaction timescales described as rapid).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:29.986658+00:00"}
{"study_id": 20297, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether hypochlorous acid (HOCl) could effectively inactivate cancer cells and stimulate innate immunity as a potential complement to current HIPEC regimens for peritoneal carcinomatosis.", "results_summary": "HOCl showed the most potent effects in reducing metabolic activity, inducing regulated cell death, and increasing pro-immunogenic danger signals (CRT, HSP70, HSP90) in cancer cells, while non-malignant cells were less affected.", "population_specificity": "Human abdominal cancer cell lines (HT-29, Panc-01, SK-OV-3) and non-malignant HaCaT keratinocytes.", "effective_dosage": "Different concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:31.374275+00:00"}
{"study_id": 20298, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether hypochlorous acid (HOCl) as a topical wound solution, combined with a prescribed exercise regimen, improves healing outcomes in venous leg ulcers (VLUs) compared to usual care and placebo.", "results_summary": "The abstract does not provide results, as the study is ongoing. Outcomes will include healing rates at 12 and 24 weeks, time to healing, ulcer area changes, and safety measures.", "population_specificity": "Adults with venous leg ulcers (VLUs).", "effective_dosage": "Not specified (active HOCl wound solution applied at each dressing change).", "study_duration": "Up to 24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:32.131624+00:00"}
{"study_id": 20299, "supplement_id": 1219, "safety_score": "90", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the virucidal efficacy and tolerability of AOS2020, a hypochlorous acid solution, against SARS-CoV-2 in vitro and its safety on nasal and oral mucosa.", "results_summary": "AOS2020 demonstrated >99.8% virucidal efficacy against SARS-CoV-2 in under 1 minute and was found to be non-irritant to nasal and oral mucosa.", "population_specificity": "In vitro testing (human coronavirus SARS-CoV-2) and mucosal irritation tests (nasal and oral mucosa).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:34.285592+00:00"}
{"study_id": 20300, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and evaluate a lysosome-targetable two-photon fluorescent probe (Lyso-TP-HClO) for imaging hypochlorous acid (HClO) in arthritis diagnosis and treatment evaluation.", "results_summary": "The study found that Lyso-TP-HClO exhibited high selectivity and sensitivity for HClO, with excellent imaging performance (low autofluorescence, photostability, and deep imaging). It successfully visualized lysosomal HClO in bacteria-infected cells and arthritis models in mice.", "population_specificity": "Bacteria-infected cells and arthritis models in mice.", "effective_dosage": "Not specified (probe tested in linear range of 10.0 \u00d7 10^-8 to 5.0 \u00d7 10^-6 M).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:36.042518+00:00"}
{"study_id": 20302, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the disinfection efficiencies of chlorine dioxide and weak acid hypochlorous water (WAHW) in hospital settings, examining seasonal effects and disinfection frequency.", "results_summary": "WAHW reduced bacteria and fungi concentrations but was less effective than chlorine dioxide. No significant difference was found between single-daily and twice-daily disinfection modes when using WAHW.", "population_specificity": "Hospital infectious disease ward environments (soiled room and dishwashing room) in Taiwan.", "effective_dosage": "Not specified (disinfection modes: single-daily and twice-daily).", "study_duration": "Conducted in winter and summer (seasonal comparison).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:37.785698+00:00"}
{"study_id": 20304, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a probe for detecting hypochlorous acid (HClO) in vitro and in vivo to understand its role in pathophysiological processes and monitor wound diseases.", "results_summary": "The probe demonstrated rapid, selective, and sensitive detection of HClO in mimic inflammatory cells, endotoxin-induced liver injury, and rheumatoid arthritis in mice, with low cytotoxicity and successful real-time monitoring of HClO in wounds.", "population_specificity": "Living cells (in vitro) and live mice (in vivo).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:37.977653+00:00"}
{"study_id": 20301, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a kinetic model to understand the oxidation of bromide by hypochlorous acid and molecular chlorine in drinking water disinfection, focusing on the catalytic impact of carbonate species.", "results_summary": "The study found that carbonate species significantly enhance the catalytic oxidation of bromide by hypochlorous acid, increasing the rate constant nearly twofold, and enable oxidation by molecular chlorine above pH 7 in high-alkalinity waters.", "population_specificity": "Drinking water treatment systems (in vitro study, no human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:37.993907+00:00"}
{"study_id": 20305, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and evaluate a bimodal phosphorescence-MR imaging probe (Ru-AN-Gd) for detecting hypochlorous acid (HClO) in vitro and in vivo.", "results_summary": "The probe effectively detected HClO across a wide concentration range (0.6-2000 \u03bcM) and enabled imaging at various resolutions, from subcellular to whole-body levels. It demonstrated applicability in live cells, a mouse arthritis model, and drug-induced acute liver and kidney injury.", "population_specificity": "In vitro (live cells) and in vivo (mouse models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:40.101788+00:00"}
{"study_id": 20306, "supplement_id": 1219, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to study the formation and decomposition kinetics of N-chloro-N-methyl amino acids to understand their behavior in water treatment and biological systems.", "results_summary": "The study found that N-methyl-N-chloro amino acids decompose faster than nonsubstituted compounds, with reaction rates independent of pH. Under physiological pH, the reactions produced aldehydes and methylamine, which are not highly toxic.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:40.162564+00:00"}
{"study_id": 20303, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the relationship between Hypochlorous Acid (HOCl) and Acute Lung Injury (ALI) by developing a fluorescent probe to monitor HOCl levels in living cells and in vivo.", "results_summary": "The study found that HOCl levels significantly increased with the severity of ALI, suggesting its crucial role in the disease process. The probe BCy-HOCl effectively monitored HOCl with high selectivity and sensitivity.", "population_specificity": "ALI cell models and ALI mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:40.300195+00:00"}
{"study_id": 20307, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the mechanisms behind the increased immunogenicity of HOCl-treated tumor cell lysates in dendritic cell-based vaccines.", "results_summary": "HOCl treatment induced protein oxidation, mitochondrial biogenesis, and stress-response activation in tumor cells. DCs loaded with HOCl-treated lysates showed increased HLA-II presentation, leading to enhanced CD4+ T cell responses in a clinical trial.", "population_specificity": "Human melanoma cell line and monocyte-derived dendritic cells (mo-DCs); phase I clinical trial patients.", "effective_dosage": "One-hour HOCl incubation (specific concentration not provided).", "study_duration": "Not specified for in vitro experiments; phase I trial duration not detailed.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:43.016292+00:00"}
{"study_id": 20310, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the physiological consequences of hypochlorous acid (HOCl) stress on bacteria and examine bacterial defense mechanisms against HOCl.", "results_summary": "The study found that HOCl is a potent antimicrobial agent produced by neutrophils, and Gram-negative bacteria have evolved diverse posttranslational defense mechanisms, including chaperone activation and polyphosphate accumulation, to protect against HOCl-mediated damage.", "population_specificity": "Gram-negative bacteria (specifically Escherichia coli)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:46.029398+00:00"}
{"study_id": 20308, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine how hypochlorous acid and other food additives affect the chemical and biological properties of vitamin B12 in aqueous solutions and food.", "results_summary": "Hypochlorous acid rapidly reacted with free cyanocobalamin, degrading it within 1 hour, but did not significantly affect vitamin B12 content in shrimp and beef, likely due to its protein-bound form in food. Sodium metabisulfite and sodium sulfite showed minimal effects on cyanocobalamin.", "population_specificity": "In vitro study (vitamin B12 in aqueous solution and food samples)", "effective_dosage": "Hypochlorous acid water (30 ppm effective chlorine concentration)", "study_duration": "Up to 48 hours", "interactions": "Reacts with free cyanocobalamin in solution but not with protein-bound vitamin B12 in food.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:46.034148+00:00"}
{"study_id": 20309, "supplement_id": 1219, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and clinical effectiveness of hypochlorous acid (HOCl) solution used with negative pressure wound therapy with instillation and dwell time (NPWTi-d) for managing septic open abdomen (OA) patients.", "results_summary": "The study found that HOCl instillation through the TAC device was safe, easy to use, and reduced the need for frequent operating room lavages in critically ill patients. No acute complications related to HOCl were reported.", "population_specificity": "Critically ill patients with septic open abdomen.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:46.588158+00:00"}
{"study_id": 20311, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential therapeutic effects of a stabilized form of hypochlorous acid (APR-TD012) on oxidative stress, proliferation, and wound healing in an in vitro model of Hailey-Hailey disease (HHD).", "results_summary": "APR-TD012 upregulated Nrf2, restored defective proliferation in ATP2C1-deficient keratinocytes, and modulated wound healing-associated cytokines, suggesting potential therapeutic benefits for HHD lesions.", "population_specificity": "In vitro model using ATP2C1-defective keratinocytes derived from Hailey-Hailey disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:46.790099+00:00"}
{"study_id": 20314, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to establish detailed mechanisms for the decomposition pathways of hypochlorous acid in aqueous solutions, focusing on oxygen and chlorate formation.", "results_summary": "The study found that both oxygen and chlorate formation proceed through identical intermediates, with the highest decomposition rates occurring at pH 7.1. Under alkaline conditions, chlorate formation proceeds through chlorite but is significantly less active.", "population_specificity": "Not specified (theoretical study using density functional theory modeling).", "effective_dosage": "Not applicable.", "study_duration": "Not applicable.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:48.246646+00:00"}
{"study_id": 20313, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of hypochlorous acid (HOCl) on myoglobin (Mb) oxidation, peroxidase-like activity, and ferric-to-ferrous reduction, as well as its potential impact on oxygen storage and transport.", "results_summary": "HOCl promoted Mb oxidation but not chlorination, altered Mb peroxidase-like activity, and reduced ferric-to-ferrous Mb reduction rates, while Mb catalase-like activity remained unchanged. These changes suggest HOCl may affect oxygen storage and transport functions.", "population_specificity": "Horse heart myoglobin (hhMb) in vitro.", "effective_dosage": "Pathological concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:49.320925+00:00"}
{"study_id": 20312, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether hypochlorous acid (HOCl) reacts with methotrexate to form new compounds at inflammation sites and how coexistent amino acids influence these reactions.", "results_summary": "The study found that HOCl reacts with methotrexate to form 3'-chloromethotrexate, and this reaction is suppressed by free amino acids like taurine. The presence of NaBr led to the formation of 3'-bromomethotrexate instead, suggesting competitive reactivity between HOCl and HOBr.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified (incubation conditions: pH 7.4, 37\u00b0C, 30 min).", "study_duration": "30 minutes.", "interactions": "Reacts with methotrexate; suppressed by free amino acids (e.g., taurine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:51.075757+00:00"}
{"study_id": 20315, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of electrolytically-generated hypochlorous acid and other antimicrobial treatments in inactivating Shiga toxin-producing Escherichia coli (STEC) in fresh beef.", "results_summary": "Electrolytically-generated hypochlorous acid had no effect on STEC inactivation in fresh beef, while caprylic acid was the most effective treatment. Sensory analysis showed no significant differences in flavor or color between caprylic acid-treated samples and reference samples.", "population_specificity": "Fresh beef samples inoculated with STEC.", "effective_dosage": "Samples were rinsed for 15\u202fs in 100\u202fmL of antimicrobial solution.", "study_duration": "Single 15-second rinse.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:51.729904+00:00"}
{"study_id": 20316, "supplement_id": 1219, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether hypochlorous acid was noninferior to 5% Sulfamylon solution in controlling infection and reducing postoperative pain in patients with skin grafts.", "results_summary": "Hypochlorous acid demonstrated equivalent efficacy and safety to 5% Sulfamylon, with no differences in graft viability, infection rates, pain scores, or adverse events, while being significantly more cost-effective.", "population_specificity": "Patients aged 18+ with thermal burns covering \u226520% total body surface area requiring excision and autografting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:54.366885+00:00"}
{"study_id": 20317, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to develop a photoactive agent (MB-DOPA) for rapid sensing of nanomolar hypochlorous acid (HOCl) and in-situ photodynamic therapy (PDT) to kill cancer cells.", "results_summary": "MB-DOPA rapidly sensed HOCl with high specificity (response time ~20 s) and exhibited strong fluorescence OFF-to-ON contrast (>3000-fold). It effectively induced apoptosis in cancer cells via in-situ photodynamic therapy by generating 1O2 species.", "population_specificity": "Cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:55.608068+00:00"}
{"study_id": 20320, "supplement_id": 1219, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the antimicrobial, anti-inflammatory, and therapeutic properties of hypochlorous acid (HOCl), focusing on a stable, pH-neutralized formulation (Microcyn\u00ae Technology) for topical applications.", "results_summary": "The study found that HOCl exhibits antimicrobial and anti-inflammatory properties, supporting its use in treating skin wounds, pruritus, diabetic ulcers, and inflammatory skin disorders. The core HOCl formulation discussed was stable for up to two years, noncytotoxic, and pH-neutralized, enhancing therapeutic activity and skin tolerability.", "population_specificity": "Not specified (in-vitro and in-vivo studies referenced, but no specific human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:55.779301+00:00"}
{"study_id": 20318, "supplement_id": 1219, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether an electrochemical scaffold generating hypochlorous acid (HOCl) could effectively eradicate biofilm-forming bacteria in wound infections without harming host tissue.", "results_summary": "The e-scaffold producing 17, 10, and 7 mM HOCl completely eradicated biofilms of S. aureus, A. baumannii, and P. aeruginosa within 1-3 hours, with no discernible harm to host tissues.", "population_specificity": "Biofilm-forming bacteria (Acinetobacter baumannii, Staphylococcus aureus, Pseudomonas aeruginosa) in wound infections.", "effective_dosage": "17 mM, 10 mM, and 7 mM HOCl.", "study_duration": "1-3 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:55.847271+00:00"}
{"study_id": 20321, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a nanoprobe (Ru@UCNPs) for specific sensing and imaging of hypochlorous acid (HOCl) in biological systems.", "results_summary": "The Ru@UCNPs nanoprobe successfully detected and visualized HOCl in aqueous solutions, cells, and mice, demonstrating selective responsiveness and background-free detection capabilities. The study also showed its application in semiquantitative HOCl detection using test papers.", "population_specificity": "In vitro (aqueous solutions, cells) and in vivo (mice) models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:56.600492+00:00"}
{"study_id": 20322, "supplement_id": 1219, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cytotoxicity and antimicrobial efficacy of six NaClO/HClO wound irrigation solutions.", "results_summary": "The study found that antimicrobial efficacy and cytotoxicity varied significantly between solutions, with higher antimicrobial activity correlating with lower cell viability. The effects were concentration- and time-dependent, with increasing NaClO/HClO concentrations and longer exposure times enhancing both cytotoxic and antimicrobial activity.", "population_specificity": "Human keratinocytes (HaCaT) and human skin fibroblasts (BJ) in vitro; pathogens tested included Staphylococcus aureus and Pseudomonas aeruginosa.", "effective_dosage": "Not specified (concentration- and time-dependent effects noted).", "study_duration": "Exposure times of 1, 5, and 15 minutes.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:06:58.108525+00:00"}
{"study_id": 20323, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether non-myeloid cells can produce hypochlorous acid (HOCl) and whether increased sodium chloride (NaCl) availability enhances its antiviral activity.", "results_summary": "The study found that epithelial, fibroblast, and hepatic cells produce HOCl, which inhibits replication of various enveloped and non-enveloped viruses in a dose-dependent manner. Antiviral activity was reversed by chloride channel and myeloperoxidase inhibitors, suggesting HOCl production depends on intracellular chloride and a peroxidase enzyme.", "population_specificity": "Epithelial, fibroblast, and hepatic cells (in vitro).", "effective_dosage": "Increasing concentrations of NaCl (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:00.254953+00:00"}
{"study_id": 190154, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Hypochlorous Acid or its study.", "results_summary": "The abstract does not discuss Hypochlorous Acid or its effects.", "population_specificity": "Not specified (abstract focuses on COVID-19 clinical phenomena).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:00.672136+00:00"}
{"study_id": 190153, "supplement_id": 1219, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the biochemical mechanisms by which \u03b2-alanine (via carnosine) scavenges hypochlorous acid (HOCl) and its potential benefits for brain health and cognitive function.", "results_summary": "The study found that carnosine, elevated by \u03b2-alanine supplementation, scavenges hypochlorous acid (HOCl) and exhibits antioxidant, anti-glycating, anti-inflammatory, and metal ion-chelating properties, which may support cognitive health. These effects are mediated through mechanisms involving BDNF, Nrf2, and TrkB activation.", "population_specificity": "Not specified (general mammalian/human brain health implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:02.674044+00:00"}
{"study_id": 21226, "supplement_id": 1220, "safety_score": "20", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether MK-0677 (Ibutamoren) improves functional recovery and increases IGF-1 levels in elderly hip fracture patients.", "results_summary": "MK-0677 increased IGF-1 levels significantly but showed limited functional improvement, with only gait speed showing a statistically significant benefit. The trial was terminated early due to safety concerns, including congestive heart failure.", "population_specificity": "Elderly patients admitted for hip fracture (n = 123).", "effective_dosage": "25mg/day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:03.902559+00:00"}
{"study_id": 21225, "supplement_id": 1220, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if ibutamoren could inhibit the MDM2-p53 interaction and reactivate p53's tumor-suppressive functions in cancer cells.", "results_summary": "In silico and in vitro analyses showed ibutamoren effectively binds to MDM2 and reduces cancer cell viability in cells with functional MDM2-p53 pathways but not in those with damaging mutations. RT-qPCR confirmed differential expression of p53 target genes in responsive cell lines.", "population_specificity": "Immortalized cancer cell lines with functional or mutated MDM2-p53 pathways.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:04.751494+00:00"}
{"study_id": 21227, "supplement_id": 1220, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and GH/IGF responses of two dosages of oral ibutamoren mesylate in children with GH deficiency over a short-term period.", "results_summary": "Short-term administration of ibutamoren mesylate increased GH, IGF-I, and IGFBP-3 levels in some children with GH deficiency, with no significant changes in other hormonal or metabolic markers. The higher dose (0.8 mg/kg) showed statistically significant increases in GH and IGF-related parameters.", "population_specificity": "18 prepubertal children (15 male, 3 female) with idiopathic GH deficiency.", "effective_dosage": "0.2 mg/kg/day and 0.8 mg/kg/day.", "study_duration": "7 to 8 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:05.954754+00:00"}
{"study_id": 20124, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of idebenone oral therapy versus rAAV2-ND4 intravitreal injection in improving visual outcomes for patients with Leber's hereditary optic neuropathy.", "results_summary": "Idebenone provided better visual improvement at 1 year compared to rAAV2-ND4, with a mean difference of 0.35 (P < 0.0001). However, rAAV2-ND4 showed better results at 6 months, and no data was available for idebenone at 2 years.", "population_specificity": "Patients with Leber's hereditary optic neuropathy (645 patients from 17 studies, 338 treated with idebenone).", "effective_dosage": "Not available", "study_duration": "1 year (for idebenone's primary efficacy data)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:07.003717+00:00"}
{"study_id": 20125, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize novel idebenone derivatives and investigate their protective effects and mechanisms against oxidative stress injury in H9C2 cells and Balb/c mice.", "results_summary": "IDE-1 showed the highest antioxidant activity among the derivatives, reducing intracellular ROS levels and potentially modulating oxidation-related (HO-1) and apoptosis-related (Bcl-2/Bax, caspase-3) pathways. The study suggests IDE derivatives could be a promising direction for treating oxidative stress-related cardiovascular diseases.", "population_specificity": "H9C2 cells (rat cardiomyocytes) and Balb/c mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:07.770827+00:00"}
{"study_id": 20126, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate Idebenone's role as a treatment for Leber's hereditary optic neuropathy (LHON), focusing on its ability to bypass Complex I deficiency and mitigate mitochondrial dysfunction.", "results_summary": "Idebenone was found to be effective in treating LHON by acting as an intramitochondrial antioxidant and shuttling electrons directly to Complex III, bypassing the defective Complex I. Clinical trials supported its approval in the EU for LHON treatment in 2015.", "population_specificity": "Patients with Leber's hereditary optic neuropathy (LHON).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:08.871250+00:00"}
{"study_id": 20127, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To investigate whether idebenone alleviates mitochondrial dysfunction in corneal endothelial cells under oxidative stress.", "results_summary": "Idebenone improved cell viability and mitochondrial membrane potential in both normal and Fuchs endothelial corneal dystrophy (FECD) cells, reducing mitochondrial fragmentation by 32% more than MitoQ in normal cells and 13% more in FECD cells. It also enhanced mitochondrial function by 31% under ultraviolet-A stress.", "population_specificity": "Immortalized human corneal endothelial cells (normal and FECD-affected).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:08.884559+00:00"}
{"study_id": 20128, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of idebenone on cognitive function and serum biomarkers (SOD and hs-CRP) in individuals with amnestic mild cognitive impairment (aMCI).", "results_summary": "Idebenone treatment significantly improved MoCA scores and delayed recall, increased SOD levels, and reduced hs-CRP levels, indicating enhanced cognitive function, reduced oxidative stress, and lower inflammation. No significant changes were observed in the control group.", "population_specificity": "Individuals with newly diagnosed amnestic mild cognitive impairment (aMCI).", "effective_dosage": "30 mg oral idebenone three times daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:12.847156+00:00"}
{"study_id": 20130, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To assess whether idebenone can bypass mitochondrial complex I to overcome drug resistance in a rotenone-induced refractory epilepsy mouse model.", "results_summary": "Idebenone successfully abolished drug resistance in the RCK model, elevated ATP and NQO1 levels, and demonstrated antioxidant effects by increasing GSH and reducing TBARS.", "population_specificity": "Rotenone corneal kindling (RCK) mouse model of mitochondrial refractory epilepsy.", "effective_dosage": "10, 20, and 40 mg/kg intraperitoneally for 10 days.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:13.047144+00:00"}
{"study_id": 20131, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and evaluate a novel nasal delivery system (nanocomposite microspheres) for Idebenone to enhance its bioavailability and therapeutic potential in Alzheimer's disease.", "results_summary": "The study successfully developed bioadhesive nanocomposite microspheres with high production yield, good drug entrapment efficiency, and no chemical interactions between Idebenone and polymers. The carrier showed potential for targeted nose-to-brain delivery, which may increase brain tissue concentrations and reduce systemic side effects.", "population_specificity": "Not specified (in vitro and ex vivo assessments, no human subjects mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:15.222272+00:00"}
{"study_id": 20133, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify idebenone as a potential oral small molecule GLP-1 receptor agonist and evaluate its effects on insulin secretion and blood glucose levels.", "results_summary": "Idebenone was found to bind potently with GLP-1R, elevate intracellular cAMP levels, enhance glucose-stimulated insulin secretion, and reduce blood glucose in mice via GLP-1R agonism, with no species differences observed.", "population_specificity": "Rat pancreatic \u03b2 cells and C57BL/6, Glp-1r-/-, and hGlp-1r mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:15.918356+00:00"}
{"study_id": 20134, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Idebenone could improve visual acuity in a patient with LHON associated with the rare m.3866T>C variant.", "results_summary": "After initiating Idebenone treatment, the patient's best-corrected visual acuity improved from 20/100 and 20/50 to 20/32 in both eyes and then stabilized, suggesting a potential therapeutic benefit.", "population_specificity": "A 59-year-old Caucasian woman with LHON linked to the m.3866T>C variant and a history of smoking and harmful alcohol consumption.", "effective_dosage": "900 mg per day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:16.484783+00:00"}
{"study_id": 20135, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 45, "study_goal": "The researchers aimed to assess changes in visual function in LHON patients using fMRI before and after idebenone treatment, given the limitations of subjective testing.", "results_summary": "Post-treatment, one patient showed positive trends in subjective tests, symptoms, and fMRI; two had stable symptoms and fMRI responses; one improved in subjective tests but worsened slightly in another; and one improved in visual field tests despite worsening symptoms and fMRI trends.", "population_specificity": "Four confirmed LHON patients.", "effective_dosage": "900 mg/day orally.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:18.086782+00:00"}
{"study_id": 20136, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone could attenuate doxorubicin (DOX)-induced cardiotoxicity by inhibiting ferroptosis and to elucidate its underlying mechanism.", "results_summary": "Idebenone significantly reduced DOX-induced cardiac dysfunction by regulating Fe2+ and ROS overload, thereby inhibiting ferroptosis. It stabilized FSP1 protein levels by inhibiting ubiquitination degradation, without affecting Fsp1 mRNA levels.", "population_specificity": "Preclinical study (animal model, likely mice or rats based on methodology).", "effective_dosage": "Single intraperitoneal injection of DOX (15 mg/kg); idebenone dosage not specified.", "study_duration": "Not specified (acute study implied by single injection).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:18.386127+00:00"}
{"study_id": 20138, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether idebenone could counteract statin-induced myotoxicity in atherosclerotic ApoE-/- mice and explore the underlying mechanisms.", "results_summary": "Idebenone treatment ameliorated impaired exercise capacity caused by simvastatin, reduced plaque formation, and mitigated oxidative stress and mitochondrial dysfunction. The study demonstrated idebenone's ability to counteract statin-induced myotoxicity by protecting mitochondrial function.", "population_specificity": "Atherosclerotic ApoE-/- mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:20.951872+00:00"}
{"study_id": 20140, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of idebenone combined with butylphthalide in treating vascular dementia compared to butylphthalide alone.", "results_summary": "The combined treatment improved cognitive function, reduced inflammatory and oxidative stress markers, and enhanced daily living activities more effectively than butylphthalide alone, with no significant difference in adverse reactions between groups.", "population_specificity": "126 patients with vascular dementia.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:23.259420+00:00"}
{"study_id": 20139, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Idebenone, alone or combined with photobiomodulation, on autophagy and muscle degeneration in dystrophic muscle cells and quadriceps muscle.", "results_summary": "Idebenone treatment increased autophagy markers and signaling pathways, reduced muscle degeneration markers, and improved muscle regeneration by modulating key proteins like myogenin and MHC-slow. The combination with photobiomodulation showed enhanced effects.", "population_specificity": "Dystrophic muscle cells (in vitro) and mdx mice (in vivo), a model for Duchenne muscular dystrophy.", "effective_dosage": "0.06\u03bcM (in vitro), 200mg/kg (in vivo).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:23.892024+00:00"}
{"study_id": 20141, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of idebenone (900 mg/day) in treating Leber hereditary optic neuropathy (LHON) up to 5 years after symptom onset over a 24-month treatment period.", "results_summary": "The study confirmed the long-term efficacy of idebenone in stabilizing and restoring vision in LHON patients, with treatment effects varying by disease phase and causative mtDNA mutation. The primary endpoint was met, demonstrating idebenone's effectiveness in subacute/dynamic and chronic phases of LHON.", "population_specificity": "Patients with Leber hereditary optic neuropathy (LHON) up to 5 years after symptom onset (N = 199).", "effective_dosage": "900 mg/day", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:25.273988+00:00"}
{"study_id": 20142, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of idebenone in sepsis and systemic inflammation models.", "results_summary": "Idebenone significantly improved survival rates, reduced tissue damage, and decreased inflammatory markers in murine sepsis and systemic inflammation models. It also suppressed inflammatory responses in macrophages by inhibiting the NF-\u03baB pathway and reducing oxidative stress.", "population_specificity": "Murine models (mice) with cecal ligation puncture-induced sepsis and lipopolysaccharide-induced systemic inflammation.", "effective_dosage": "Various concentrations (specific amounts not detailed in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:25.566685+00:00"}
{"study_id": 20143, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Idebenone's potential as a therapeutic agent for triple-negative breast cancer (TNBC) by examining its effects on TNBC cell lines and xenograft mouse models.", "results_summary": "Idebenone inhibited TNBC cell proliferation, migration, and invasion, suppressed apoptosis, and halted the cell cycle in the G2/M phase. It disrupted mitochondrial membrane potential, promoted mitophagy, and induced autophagy via the AMPK/mTOR pathway, also showing inhibitory effects in vivo.", "population_specificity": "TNBC cell lines and xenograft mouse models.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:26.774881+00:00"}
{"study_id": 20144, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to understand why some patients with Leber hereditary optic neuropathy (LHON) do not respond to Idebenone treatment, focusing on the role of NQO1 genetic variants and mitochondrial DNA mutations.", "results_summary": "The study found that Idebenone's effectiveness is reduced in patients with homozygous or compound heterozygous NQO1 variants, particularly those with the m.3460G>A/MT-ND1 LHON mutation, due to impaired drug reduction and subsequent inhibition of complex I.", "population_specificity": "Patients with Leber hereditary optic neuropathy (LHON) treated with Idebenone.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:27.543099+00:00"}
{"study_id": 20145, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone could enhance retinal function and promote photoreceptor cell survival and synaptogenesis in a mouse model of retinitis pigmentosa.", "results_summary": "Idebenone improved retinal function and supported photoreceptor survival and inner retinal synaptogenesis in rd1 mice by postnatal day 14, suggesting mitochondrial protection as a key mechanism.", "population_specificity": "Pde6brd1/rd1 (rd1) mice, a model for autosomal recessive retinitis pigmentosa.", "effective_dosage": "Not specified", "study_duration": "Administered until postnatal day 14", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:30.777180+00:00"}
{"study_id": 20146, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effect of idebenone on visual function and quality of life in patients with OPA1-dominant optic atrophy (DOA).", "results_summary": "Idebenone treatment led to significant improvements in visual acuity, visual fields, and vision-related quality of life, though the improvements were small. The study also noted maintenance of visual function over 12 months, but the exact cause of these effects (idebenone, placebo, or natural progression) remains unclear.", "population_specificity": "Sixteen patients with genetically confirmed OPA1-DOA.", "effective_dosage": "900 mg daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:32.243556+00:00"}
{"study_id": 20129, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how Idebenone (IDE) might treat diabetic retinopathy by examining its effects on vascular function, retina structure, and biomarkers of autophagy and apoptosis.", "results_summary": "IDE reversed vascular dysfunction and disordered retina structure in diabetic rats, suppressed apoptosis and autophagy both in vivo and in vitro, and regulated the PI3K signaling pathway to alleviate diabetic retinopathy.", "population_specificity": "Diabetic rats and the retina endothelial cell line RF/6A.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:32.750215+00:00"}
{"study_id": 20149, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether idebenone, alone or combined with donepezil, could modulate serum levels of BDNF, Hcy, NO, and IFN-\u03b3 in elderly patients with vascular dementia post-cerebral infarction.", "results_summary": "Idebenone, when combined with donepezil, significantly reduced serum levels of Hcy and IFN-\u03b3 while increasing BDNF and NO levels compared to donepezil alone, suggesting a potential therapeutic benefit.", "population_specificity": "Elderly patients with vascular dementia following cerebral infarction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:33.549113+00:00"}
{"study_id": 20150, "supplement_id": 1221, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of idebenone on respiratory parameters, cell growth, and mtDNA amounts in fibroblasts from subjects with LHON pathogenic variants.", "results_summary": "LHON fibroblasts showed reduced respiratory parameters without significant improvement after idebenone treatment. The treatment did not exhibit major toxicity or compensatory effects on mtDNA quantity.", "population_specificity": "Fibroblast lines from eight subjects carrying LHON pathogenic variants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:34.498118+00:00"}
{"study_id": 20151, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of idebenone, alone or combined with LEDT, on calcium and mitochondrial signaling pathways in dystrophic muscle cells from mdx mice, a model of Duchenne muscular dystrophy.", "results_summary": "Idebenone treatment reduced intracellular calcium content, oxidative stress markers, and improved mitochondrial function, with slightly better results when combined with LEDT.", "population_specificity": "Dystrophic primary muscle cells from mdx mice (experimental model of Duchenne muscular dystrophy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:34.987124+00:00"}
{"study_id": 20152, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-atherosclerotic effect of combining idebenone and rosuvastatin compared to using either substance alone.", "results_summary": "Idebenone and rosuvastatin both reduced plaque burden and increased plaque stability in ApoE-/- mice, with the combination therapy showing superior effects, including further downregulation of NLRP3 and IL-1\u03b2, reduced oxidative stress, and decreased cell apoptosis.", "population_specificity": "Apolipoprotein E knockout (ApoE-/-) mice", "effective_dosage": "400 mg/kg/d idebenone, 10 mg/kg/d rosuvastatin", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:36.804739+00:00"}
{"study_id": 20147, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness of Idebenone in managing patients with Leber's hereditary optic neuropathy (LHON) at different disease stages.", "results_summary": "The study found mixed results, with one female patient showing good outcomes after Idebenone treatment, while another male patient experienced delayed visual improvement after deferred treatment. Long-term use (36 months) in one case resulted in good outcomes.", "population_specificity": "Patients with LHON carrying the 11778G>A mutation in MT-ND4, including an 82-year-old man, a 40-year-old brother, a 31-year-old sister, and a 46-year-old man.", "effective_dosage": "Not specified", "study_duration": "Ranged from 1 year to 36 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:38.312259+00:00"}
{"study_id": 20153, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare neuroretinal structure differences between childhood-onset and early teenage-onset LHON patients treated with Idebenone.", "results_summary": "The study found less neuroaxonal tissue degeneration and better functional outcomes in childhood-onset LHON patients compared to early teenage-onset patients, suggesting Idebenone may be more effective in younger patients.", "population_specificity": "Young patients with Leber hereditary optic neuropathy (LHON), divided into childhood-onset (\u226412 years) and early teenage-onset (13-16 years) groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:39.115431+00:00"}
{"study_id": 20154, "supplement_id": 1221, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "To evaluate the effects of paroxetine hydrochloride combined with idebenone on inflammatory factors, antioxidant molecules, and clinical efficacy in treating depression after ischemic stroke.", "results_summary": "The combination treatment significantly improved HRSD scores, reduced inflammatory factors (TNF-a, CRP, IL-6), and increased antioxidant molecules (SOD, TAC, CAT) compared to paroxetine alone, with a higher effective rate (82.5% vs. 62.5%). Adverse reactions were more frequent in the combination group but not statistically significant.", "population_specificity": "80 patients with depression after ischemic stroke.", "effective_dosage": "Not specified.", "study_duration": "March 17, 2019 to December 20, 2021 (exact intervention duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:42.554480+00:00"}
{"study_id": 20156, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Idebenone on oxidative stress markers, antioxidant defense systems, intracellular calcium concentrations, and inflammatory processes in dystrophic muscle cells from mdx mice, a model for Duchenne muscular dystrophy (DMD).", "results_summary": "Idebenone reduced oxidative stress markers (H2O2 and 4-HNE), decreased intracellular calcium influx, upregulated antioxidant enzymes (catalase, GR, GPx, SOD), and lowered inflammatory molecules (NF-\u03baB, TNF) in dystrophic muscle cells without cytotoxicity.", "population_specificity": "Primary dystrophic muscle cells from mdx mice (DMD model).", "effective_dosage": "0.05 \u03bcM for 24 hours.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:42.970691+00:00"}
{"study_id": 20155, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 40, "study_goal": "The researchers aimed to determine whether idebenone could improve sperm motility and fertility in a patient with Leber hereditary optic neuropathy (LHON) and suspected mitochondrial dysfunction.", "results_summary": "After 5 months of idebenone treatment, the patient's sperm motility and vitality improved, leading to a natural conception. The study suggests idebenone may benefit spermatogenesis in LHON patients with mitochondrial DNA mutations.", "population_specificity": "A 30-year-old male with LHON and infertility due to sperm abnormalities.", "effective_dosage": "Not specified", "study_duration": "5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:43.537566+00:00"}
{"study_id": 20157, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to identify OCT biomarkers linked to long-term visual outcomes in LHON patients treated with idebenone within the first year of disease onset.", "results_summary": "Idebenone treatment was associated with significant improvement in BCVA over 2 years, with specific macular GC-IPL thicknesses (superior and temporal regions) strongly correlating with visual outcomes. Thinner GC-IPL in these regions predicted worse long-term vision.", "population_specificity": "17 participants (34 eyes) with LHON, treated within 1 year of disease onset.", "effective_dosage": "Not specified", "study_duration": "2 years (24 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:43.716713+00:00"}
{"study_id": 20158, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of idebenone in delaying or preventing the conversion of idiopathic REM sleep behavior disorder (iRBD) into synucleinopathies.", "results_summary": "The study is ongoing, so no results are reported yet; it focuses on the 5-year conversion rate of iRBD and the safety/tolerability of idebenone.", "population_specificity": "142 patients aged 40-75 years with clinically diagnosed iRBD.", "effective_dosage": "30 mg three times a day.", "study_duration": "5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:44.735916+00:00"}
{"study_id": 20159, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the effectiveness of Idebenone in improving visual function in patients with Leber hereditary optic neuropathy (LHON) based on their genetic mutations.", "results_summary": "One patient with the 3460G>A mutation showed improvement in visual acuity, visual field, and visual evoked potentials, while the patient with the 11778G>A mutation showed no functional or morphological recovery after one year of Idebenone treatment. The study suggests Idebenone's efficacy may depend on the genetic profile of LHON.", "population_specificity": "Two male patients with genetically confirmed LHON (3460G>A and 11778G>A mutations).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:45.917541+00:00"}
{"study_id": 20160, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone-loaded PVA/calcium alginate scaffolds could promote diabetic wound healing by reducing oxidative stress and modulating inflammatory responses.", "results_summary": "Scaffolds loaded with 1% idebenone showed significantly better protection under oxidative stress, higher cell viability, and improved wound healing in diabetic rats, including faster wound size reduction, increased collagen deposition, and enhanced epithelial thickness. Gene expression studies indicated modulation of inflammatory response, oxidative stress protection, and increased angiogenesis-related genes.", "population_specificity": "Diabetic rats with induced wounds.", "effective_dosage": "1 w/w%, 2 w/w%, and 3 w/w% idebenone in scaffolds (1% was selected for in vivo testing).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:48.534859+00:00"}
{"study_id": 20161, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To evaluate the therapeutic effects of idebenone, alone and combined with methylprednisolone, on optic nerve and retinal damage in rats following methanol intoxication.", "results_summary": "Idebenone, especially when combined with methylprednisolone, showed significant improvements in optic nerve and retinal histopathology, including reduced vacuolization and astrocyte increase, though no significant differences were found in biochemical biomarkers.", "population_specificity": "Male Wistar rats with methanol-induced optic nerve and retinal damage.", "effective_dosage": "20 mg/kg idebenone administered via nasogastric catheter.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:48.962346+00:00"}
{"study_id": 20162, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the efficacy of idebenone in improving muscle strength in patients with hereditary myopathies.", "results_summary": "The study found modest increases in muscle strength (e.g., biceps and ilio-lumbar muscles) and sit-up capacity, though these improvements were not statistically significant. The authors concluded that the positive trends were clinically meaningful despite the lack of statistical significance.", "population_specificity": "9 patients with hereditary myopathies, including hereditary ataxia.", "effective_dosage": "90 mg daily.", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:50.687488+00:00"}
{"study_id": 20163, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the long-term effects of idebenone on visual function and retinal ganglion cell layer thickness in Dutch patients with Leber's Hereditary Optic Neuropathy (LHON).", "results_summary": "Idebenone treatment resulted in clinically relevant recovery (CRR) in 53% of patients and clinically relevant stabilization (CRS) in 11%. However, retinal neural tissue thinning appeared irreversible.", "population_specificity": "Dutch patients with LHON confirmed by mitochondrial DNA mutations affecting complex I subunits.", "effective_dosage": "Not specified", "study_duration": "Mean treatment duration was 23.8 \u00b1 14.4 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:51.813017+00:00"}
{"study_id": 20165, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate the safety and efficacy of Idebenone/naproxen co-loaded aspasomes as an anti-inflammatory nanomedicine for dermal and transdermal delivery.", "results_summary": "Idebenone/naproxen co-loaded aspasomes demonstrated increased therapeutic efficacy compared to a commercially available gel, with rapid reduction of chemical-induced erythema in human volunteers. The aspasomes showed suitable physicochemical properties and were safe for topical application.", "population_specificity": "Human healthy volunteers", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:51.856802+00:00"}
{"study_id": 20166, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop and characterize idebenone-loaded PLGA microspheres for intravitreal administration to evaluate their potential as a long-term therapeutic approach for Leber's Hereditary Optic Neuropathy (LHON).", "results_summary": "The study found that idebenone-loaded PLGA microspheres had appropriate production yield, encapsulation efficiency, and loading values, with no cytotoxic effects in an organotypic tissue model. The microspheres showed potential for long-term idebenone administration with a biexponential kinetic release profile.", "population_specificity": "Not specified (in vitro and organotypic tissue model used).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:53.591110+00:00"}
{"study_id": 20164, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore idebenone's cytoprotective effect on retinal pigment epithelium (RPE) cells and its underlying mechanism against oxidative damage.", "results_summary": "Idebenone improved cell viability, activated the Nrf2 pathway, reduced the Bax/Bcl-2 ratio, maintained mitochondrial membrane potential, and decreased caspase-3 activity, protecting RPE cells from oxidative damage.", "population_specificity": "Human retinal pigment epithelium (ARPE-19) cell line", "effective_dosage": "Not specified", "study_duration": "24 hours pre-treatment, followed by 24 hours of oxidative damage induction", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:53.911417+00:00"}
{"study_id": 20167, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone (IDB) supplementation could improve the maturation and developmental competence of porcine oocytes exposed to heat stress (HS).", "results_summary": "IDB supplementation significantly improved oocyte maturation, blastocyst rate, antioxidant capacity (reduced ROS, increased GSH), mitochondrial function (higher membrane potential and ATP synthesis), and expression of developmental genes (GDF9, BMP15) under HS conditions.", "population_specificity": "Porcine cumulus-oocyte complexes (COCs)", "effective_dosage": "0.1, 1, and 10 \u03bcM", "study_duration": "44 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:54.522537+00:00"}
{"study_id": 20168, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of idebenone on Alzheimer's disease pathology, specifically amyloidopathy and tauopathy, in a 5xFAD mouse model.", "results_summary": "Idebenone significantly reduced A\u03b2 plaque number by modulating RAGE/caspase-3 signaling, increasing A\u03b2-degrading enzymes (NEP and ADAM17), and suppressing tau hyperphosphorylation by inhibiting p-GSK3\u03b2Y216. These findings suggest idebenone has therapeutic potential for Alzheimer's disease.", "population_specificity": "5xFAD mice (a model of Alzheimer's disease)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:57.466501+00:00"}
{"study_id": 20169, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to predict potential targets of Idebenone and explore its therapeutic mechanism against Parkinson's disease (PD).", "results_summary": "Idebenone was found to enhance autophagy and promote \u03b1-synuclein degradation by suppressing the AKT/mTOR pathway, demonstrating potential anti-PD effects. Molecular docking confirmed tight binding with AKT and MAPK, supporting its pharmacological targets.", "population_specificity": "SH-SY5Y cell line overexpressing mutant \u03b1-synuclein (in vitro model of PD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:57.555076+00:00"}
{"study_id": 20170, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to report plasma idebenone values in Friedreich's ataxia (FRDA) patients during long-term follow-up and assess its correlation with cardiological and neurological status.", "results_summary": "Median plasma idebenone levels increased with higher doses, but linearity was lost at the highest dose. No consistent positive effects were found, though a weak correlation between cardiological measures and high-dose therapy duration was observed.", "population_specificity": "27 FRDA patients with pediatric disease onset treated with idebenone via compassionate use.", "effective_dosage": "Not specified", "study_duration": "Long-term follow-up (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:59.409500+00:00"}
{"study_id": 20171, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the feasibility and characteristics of prolonged and controlled idebenone release from a PCL intravitreal implant for treating Leber's Hereditary Optic Neuropathy (LHON).", "results_summary": "The study demonstrated successful controlled and prolonged idebenone delivery from PCL implants in an in vitro model, establishing a preclinical base for long-term sustained intraocular delivery as a potential LHON treatment strategy.", "population_specificity": "Preclinical (in vitro model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:00.021681+00:00"}
{"study_id": 20173, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Idebenone, as a Shc inhibitor, could effectively treat nonalcoholic steatohepatitis (NASH) in mouse models.", "results_summary": "Idebenone reduced Shc expression and phosphorylation, improved liver enzyme levels, attenuated liver fibrosis, and improved insulin resistance in two mouse models of NASH.", "population_specificity": "Mice with NASH induced by fibrotic MCD diet and metabolic fast food diet (FFD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:01.758369+00:00"}
{"study_id": 20174, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone could reduce sperm reactive oxygen species (ROS) in aged males and improve fertilization, embryo development, and pregnancy outcomes.", "results_summary": "Idebenone at 5 \u00b5M reduced sperm superoxide and intracellular ROS concentrations, improved fertilization rates, blastocyst quality, cryosurvival, and implantation rates, while also affecting placental and fetal weight ratios.", "population_specificity": "Aged human males (>40 years) and older CBAF1 mice (12-18 months).", "effective_dosage": "5 \u00b5M and 50 \u00b5M (single treatment during sperm washing).", "study_duration": "Not specified (acute in vitro treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:02.620319+00:00"}
{"study_id": 20177, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve the oral bioavailability and brain concentration of Idebenone by developing IDB nanorods (IDBNRs) to enhance its therapeutic effects in Alzheimer's disease (AD).", "results_summary": "IDBNRs improved release rate, antioxidant activity, and plasma/brain concentrations, leading to amelioration of AD-induced learning and memory impairments in mice. The study suggests IDBNRs could reduce required doses and improve patient compliance.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:03.372289+00:00"}
{"study_id": 20176, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether Idebenone could mitigate the pro-oxidant/proinflammatory environment in the placentas of F2 fetuses and prevent GDM development in F1 offspring of pregestational diabetic rats.", "results_summary": "Idebenone treatment in F0 diabetic rats prevented pro-oxidant/proinflammatory alterations in F2 placentas but did not prevent GDM development in F1 offspring. The treatment reduced nitric oxide production, peroxynitrite-induced damage, and connective tissue growth factor levels in placentas.", "population_specificity": "Pregestational diabetic female rats (F0) and their F1 and F2 offspring.", "effective_dosage": "Not specified", "study_duration": "From day 1 of gestation to term", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:03.416169+00:00"}
{"study_id": 20178, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare the effects of idebenone, resveratrol, and taurine on sperm quality and lipid peroxidation in cryopreserved crossbred ram semen.", "results_summary": "Idebenone (0.01 mM) was less effective than taurine in improving sperm quality and reducing lipid peroxidation. Sperm quality declined significantly post-thaw in all groups, including the idebenone-treated samples.", "population_specificity": "Crossbred ram semen", "effective_dosage": "0.01 mM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:05.538287+00:00"}
{"study_id": 20179, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of Idebenone against lung injury in a sepsis rat model induced by cecal ligation and puncture.", "results_summary": "Idebenone significantly reduced oxidative stress-related factors, abolished histopathological lung tissue changes, and decreased inflammatory markers (IL-1\u03b2 and TNF-\u03b1) in septic rats, with effects increasing at higher doses.", "population_specificity": "Male albino Wistar rats", "effective_dosage": "50 mg/kg, 100 mg/kg, and 200 mg/kg (single dose administered 1 hour after CLP induction)", "study_duration": "16 hours post-sepsis induction", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:06.344094+00:00"}
{"study_id": 20181, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the changes in visual function and correlations with retinal structure in acute and chronic LHON patients after treatment with idebenone.", "results_summary": "Idebenone significantly improved visual acuity in acute, early chronic, and late chronic LHON patients, with strong correlations between OCT and visual function parameters observed post-treatment. The sustained visual recovery suggests reactivated signal transduction in surviving retinal ganglion cells.", "population_specificity": "Twenty-three genetically confirmed LHON patients (acute, early chronic, and late chronic stages).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:08.049473+00:00"}
{"study_id": 20180, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the mechanism of Idebenone in treating vascular dementia (VD) by assessing its effects on cognitive function, neuroinflammation, oxidative stress, and neuronal apoptosis in a rat model.", "results_summary": "Idebenone improved learning and spatial memory, reduced oxidative stress and neuroinflammation, and prevented neuronal apoptosis in VD rats. It elevated miR-216a expression, which targeted RSK2, and its therapeutic effects were reversed by inhibiting miR-216a or overexpressing RSK2.", "population_specificity": "VD rat model (permanent occlusion of bilateral common carotid arteries)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:08.521208+00:00"}
{"study_id": 20182, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine whether regular administration of idebenone improved vision in patients with Leber's hereditary optic neuropathy (LHON).", "results_summary": "The study found that 3 out of 7 treated patients experienced vision recovery (VA 0.8-1.0), while untreated patients showed no improvement. All recovering patients carried the m.11778G>A mutation.", "population_specificity": "Newly diagnosed LHON patients at the University Eye Hospital Tuebingen.", "effective_dosage": "900 mg daily", "study_duration": "Median 23 months (range 12-35 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:09.763474+00:00"}
{"study_id": 20184, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of idebenone on ER stress, inflammation, and disease markers in a mouse model of ulcerative colitis.", "results_summary": "Idebenone improved body weight gain, disease activity index, colon length, and histopathology scores. It increased MUC2 expression and reduced ER stress markers and pro-inflammatory cytokines.", "population_specificity": "Winnie mice with spontaneous chronic intestinal inflammation and ER stress due to a MUC2 gene mutation.", "effective_dosage": "200 mg/kg orally administered daily.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:11.784247+00:00"}
{"study_id": 20183, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects and safety of idebenone in Japanese patients with Leber's hereditary optic neuropathy (LHON).", "results_summary": "Idebenone showed significant improvement in best-corrected visual acuity in 33.3% of patients, with additional improvements in visual fields and critical fusion frequency, though retinal ganglion cell layer thickness decreased. The treatment was well-tolerated with no reported adverse effects.", "population_specificity": "Japanese patients with definite LHON diagnosis, predominantly male (91.2%) and mostly carrying the mt.11778G>A mutation (94.7%).", "effective_dosage": "900 mg/day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:11.830252+00:00"}
{"study_id": 20185, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of idebenone in improving or stabilizing visual acuity in patients with Leber hereditary optic neuropathy (LHON) in a real-world clinical setting.", "results_summary": "Idebenone treatment resulted in clinically relevant recovery (CRR) in 46.0% of patients, with visual acuity improvements increasing over time, and 50% of patients maintained good residual vision. The treatment was well tolerated, with most adverse events being minor.", "population_specificity": "111 LHON patients with confirmed mitochondrial DNA mutations and symptom onset within the past year.", "effective_dosage": "900 mg/day", "study_duration": "Average treatment duration was 25.6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:12.649242+00:00"}
{"study_id": 20186, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Idebenone (IDB) has a preventive effect against amyloid beta (A\u03b2)-induced mitochondrial and neuronal stress in Alzheimer's disease.", "results_summary": "IDB pretreatment significantly prevented A\u03b2-induced mitochondrial bioenergetics collapse and PKA/CREB signaling perturbations in cortical neurons. IDB alone showed no discernible side effects on mitochondrial function, signaling, or neuronal viability.", "population_specificity": "Primary cultured cortical neurons (in-vitro setting).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:13.345422+00:00"}
{"study_id": 20187, "supplement_id": 1221, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether idebenone inhibits mitochondrial dysfunction and disability progression in primary progressive MS (PPMS) and to explore its effects on CSF biomarkers.", "results_summary": "Idebenone was well tolerated but did not inhibit disability progression or CNS tissue destruction. CSF biomarker GDF15 indicated mitochondrial dysfunction in PPMS patients, but idebenone did not alter GDF15 levels.", "population_specificity": "Patients with primary progressive multiple sclerosis (PPMS).", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:14.752129+00:00"}
{"study_id": 20189, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of nanostructured lipid carriers (NLCs) loaded with idebenone (IDE-NLCs) as a therapeutic agent for ARSACS by assessing their physicochemical properties, BBB permeability, and antioxidant efficacy.", "results_summary": "IDE-NLCs demonstrated stability, sustained drug release, and the ability to permeate an in vitro BBB model. They showed protective antioxidant activity in healthy fibroblasts and therapeutic efficacy in ARSACS-derived fibroblasts.", "population_specificity": "Human primary skin fibroblasts (healthy and ARSACS-derived) and CNS cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:17.140348+00:00"}
{"study_id": 20190, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine how Idebenone suppresses NLRP3 inflammasome activation and mitigates neuroinflammation in cerebral ischemia and reperfusion (I/R) injury.", "results_summary": "Idebenone inhibited NLRP3 inflammasome activation, reduced oxidative stress and inflammation in microglia and neurons, and improved neurological outcomes in I/R rats.", "population_specificity": "I/R rat model and in vitro BV2 microglia, primary microglia, and PC12 neuronal cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:17.409888+00:00"}
{"study_id": 20188, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether idebenone protects against atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice by improving mitochondrial dysfunction and inhibiting oxidative stress.", "results_summary": "Idebenone significantly reduced plaque burden and size, stabilized atherosclerotic plaques, and regulated the SIRT3-SOD2-mtROS pathway, protecting against endothelial cell damage and inhibiting mitochondrial reactive oxygen species (mtROS) production.", "population_specificity": "Apolipoprotein E-deficient (apoE-/-) mice on a high-fat diet.", "effective_dosage": "Low-dose (100 mg/kg/d), medium-dose (200 mg/kg/d), and high-dose (400 mg/kg/d).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:17.481296+00:00"}
{"study_id": 20192, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cytoprotective and anticataractogenic effects of idebenone in galactose-induced cataract in rats.", "results_summary": "Idebenone significantly reduced oxidative stress markers (malondialdehyde, DNA fragmentation) and apoptosis (Bax/Bcl-2 ratio) while increasing total antioxidant capacity in rat lenses, demonstrating anticataractogenic potential. However, unlike esculetin, it did not affect aldose reductase, galactitol, or advanced glycated end products.", "population_specificity": "Rats with galactose-induced cataract", "effective_dosage": "100 mg/kg body weight", "study_duration": "20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:20.361472+00:00"}
{"study_id": 20191, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether endogenous NQO1 activity limits neurons' ability to use idebenone as an electron donor for mitochondrial respiration and if NQO1 induction could enhance idebenone's efficacy in bypassing Complex I defects.", "results_summary": "Idebenone stimulated respiration in astrocytes but reduced respiratory capacity in neurons due to NQO1 deficiency. NQO1 induction or delivery enabled idebenone to bypass Complex I in cells with low NQO1 expression, suggesting combination therapy could improve idebenone's efficacy.", "population_specificity": "Primary rat cortical cells (neurons and astrocytes) pooled from both sexes and COS-7 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:21.042140+00:00"}
{"study_id": 20193, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a Zero Echo Time (ZTE) MRI sequence with ASPIR fat suppression for imaging the optic nerve in subjects with Leber's hereditary optic neuropathy (LHON).", "results_summary": "The study found that the ZTE MRI sequence with ASPIR fat suppression improved optic nerve imaging by reducing motion artifacts and involuntary saccades, enhancing image quality. The sequence's near-silent operation was particularly beneficial for this application.", "population_specificity": "Subjects with Leber's hereditary optic neuropathy (LHON).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:21.324855+00:00"}
{"study_id": 20194, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of off-label idebenone administration on visual acuity in patients with OPA1-Dominant Optic Atrophy (OPA1-DOA) compared to untreated patients.", "results_summary": "Idebenone-treated patients showed significant stabilization or recovery in visual acuity compared to untreated patients, even after controlling for confounders. The effect was consistent with prior findings of visual improvement in a smaller group.", "population_specificity": "Patients with OPA1-DOA confirmed by clinical and molecular diagnosis, and baseline visual acuity of at least counting fingers.", "effective_dosage": "Not specified", "study_duration": "Greater than 7 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:22.569263+00:00"}
{"study_id": 20195, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the therapeutic effects of idebenone on visual function in patients with Leber hereditary optic neuropathy (LHON), focusing on visual acuity, visual field defects, visual evoked potential, and retinal nerve fiber layer thickness.", "results_summary": "Idebenone improved visual acuity in both the best and worst eyes, reduced visual field defects, and increased visual evoked potential amplitude, with no significant changes in latency or retinal nerve fiber layer thickness. The treatment was safe and well-tolerated, with baseline visual acuity and VEP amplitude influencing outcomes.", "population_specificity": "30 patients with LHON due to m.3460 G > A, m.11778 G > A, and m.14484 T > C mutations.", "effective_dosage": "900 mg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:24.959364+00:00"}
{"study_id": 20196, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To determine the clinical effect of butyphthalide combined with idebenone in treating vascular dementia (VD) and its influence on inflammatory cytokines and vascular endothelial functions.", "results_summary": "The combination of butyphthalide and idebenone significantly reduced inflammatory markers, improved vascular endothelial function, and enhanced cognitive and daily living abilities compared to idebenone alone, with no significant difference in adverse reactions.", "population_specificity": "88 patients with vascular dementia.", "effective_dosage": "Not specified.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:25.465063+00:00"}
{"study_id": 20198, "supplement_id": 1221, "safety_score": "40", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the NQO1-dependent activity of idebenone, its cytotoxicity, and its therapeutic effects in LHON, including its potential toxicity in retinal cells.", "results_summary": "The study confirmed that idebenone's activation and cytotoxicity depend on NQO1 expression, with NQO1-deficient cells showing reduced viability and increased ROS production. Idebenone demonstrated a narrow therapeutic window and variable patient outcomes, with limited efficacy in clinical trials.", "population_specificity": "Patients with Leber's hereditary optic neuropathy (LHON) and mouse retinal cells ex vivo.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:26.386244+00:00"}
{"study_id": 20197, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to assess the long-term effects of idebenone on respiratory function in DMD patients by comparing periods On-Idebenone and Off-Idebenone.", "results_summary": "The study found that idebenone reduced the annual decline in FVC%p by approximately 50% and similarly improved PEF%p, with benefits maintained over several years and potential reductions in adverse respiratory events.", "population_specificity": "18 DMD patients not using glucocorticoids.", "effective_dosage": "900 mg/day", "study_duration": "Mean 4.2 years (range 2.4-6.1)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:26.419326+00:00"}
{"study_id": 20199, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone could preferentially target lung fibroblasts (myofibroblasts) in idiopathic pulmonary fibrosis (IPF) and assess its therapeutic potential compared to current treatments.", "results_summary": "Idebenone showed preferential cytotoxicity toward lung fibroblasts (LL29 cells) over alveolar epithelial cells (A549 cells), suppressed TGF-\u03b2-induced collagen production, and improved pulmonary fibrosis and lung function in bleomycin-induced fibrosis models, unlike CoQ10 or current IPF drugs.", "population_specificity": "Lung fibroblasts from an IPF patient (LL29 cells) and human lung alveolar epithelial cell line (A549 cells), with in vivo testing in bleomycin-induced pulmonary fibrosis models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:30.111261+00:00"}
{"study_id": 20201, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of idebenone treatment in patients with Leber's hereditary optic neuropathy (LHON) when initiated more than 5 years after disease onset.", "results_summary": "VA improved significantly during the first year of therapy, with seven of fourteen eyes showing an improvement of 2 or more lines. Visual field mean deviation increased but was not statistically significant.", "population_specificity": "Seven patients with genetically confirmed primary LHON mutations (m11778G>A, m14484T>C, and m13051G>A), 5 to 51 years after disease onset.", "effective_dosage": "300 mg tid (three times daily)", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:30.160610+00:00"}
{"study_id": 20200, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether idebenone could ameliorate lupus disease activity and organ damage in murine models of systemic lupus erythematosus (SLE).", "results_summary": "Idebenone significantly reduced mortality, attenuated disease features like glomerular inflammation and fibrosis, improved renal function, decreased proinflammatory cytokines, and enhanced mitochondrial metabolism in lupus-prone mice. No obvious drug toxicity was observed.", "population_specificity": "MRL/lpr and NZM2328 lupus-prone mice, and human SLE patients (for neutrophil extracellular trap formation analysis).", "effective_dosage": "1 gm/kg or 1.5 gm/kg idebenone-containing diet.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:30.231952+00:00"}
{"study_id": 20202, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the cardioprotective mechanisms of idebenone in mitigating mitochondrial dysfunction and tissue injury caused by ischemia/reperfusion (I/R) injury.", "results_summary": "Idebenone significantly reduced infarct size and improved hemodynamic function in ex vivo hearts post-ischemia. It enhanced mitochondrial respiration and oxidative phosphorylation capacity but did not attenuate ROS production, suggesting its effects are mediated through augmenting the quinone pool rather than ROS scavenging.", "population_specificity": "Ex vivo perfused hearts, isolated mitochondria, permeabilized cardiac fibers, and cells (in vitro and ex vivo models).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:32.576709+00:00"}
{"study_id": 20203, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Friedreich's ataxia patients could correctly identify their treatment allocation (idebenone or placebo) and assess subjective symptom experiences like fatigue.", "results_summary": "The study found no significant differences between idebenone and placebo groups in treatment assignment assessment or early withdrawal. A small but significant difference in ataxia rating scale scores was noted among ambulatory patients only.", "population_specificity": "Patients with Friedreich's ataxia who had been taking idebenone for at least 12 months.", "effective_dosage": "Not specified", "study_duration": "2-month treatment cycles", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:33.672840+00:00"}
{"study_id": 20204, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve Idebenone's topical effectiveness by synthesizing an ester (IDEPCA) and loading it into solid lipid nanocarriers (SLN), comparing its antioxidant, anti-glycation, and hydrating effects to IDE SLN.", "results_summary": "IDEPCA SLN and IDE SLN showed similar antioxidant and anti-glycation activity, but IDEPCA SLN demonstrated superior NO scavenging and in vivo hydrating effects in human volunteers.", "population_specificity": "Human volunteers (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:34.402703+00:00"}
{"study_id": 20207, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify new PPAR ligands with fewer toxic effects and evaluate idebenone's potential as a tissue-selective PPAR partial agonist for treating metabolic disorders.", "results_summary": "Idebenone was found to act as a spatially restricted partial agonist for PPAR\u03b1 and PPAR\u03b3, reversing fatty liver development in a mouse model of type 2 diabetes, suggesting potential for treating NAFLD and steatosis.", "population_specificity": "Transgenic zebrafish and a mouse model of type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:34.853121+00:00"}
{"study_id": 20205, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of idebenone against hepatotoxicity induced by titanium dioxide nanoparticles in rats.", "results_summary": "Idebenone significantly reduced markers of liver damage (MDA, ALT, TNF-\u03b1, IL-6, IgG, CRP) and improved liver histopathology in TiO2-NPs-exposed rats. It also modulated VEGF, NO, DNA breakage, caspase-3, and CYP4502E1 levels, demonstrating hepatoprotective effects.", "population_specificity": "Rats exposed to TiO2-NPs", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:35.047898+00:00"}
{"study_id": 20208, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if maternal idebenone treatment could prevent proinflammatory-prooxidant alterations, mitochondrial dysfunction, and increased apoptosis in embryos from mild diabetic rats.", "results_summary": "Idebenone administration prevented increased levels of nitrated proteins, 4-hydroxynonenal, and matrix metalloproteinase 9, restored mitochondrial gene expression, and reduced apoptosis in embryos from diabetic rats.", "population_specificity": "Mild diabetic pregnant rats and their embryos.", "effective_dosage": "100 mg/kg daily, orally.", "study_duration": "From day 1 of pregnancy until day 10.5 of gestation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:38.897332+00:00"}
{"study_id": 20209, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of idebenone and its metabolite QS10 on restoring mitochondrial respiration in cells with complex I or CoQ deficiencies, and to evaluate their potential therapeutic benefits in related diseases.", "results_summary": "QS10 partially restored respiration in complex I- and CoQ-deficient cells without inducing mitochondrial permeability transition, unlike idebenone. In zebrafish, QS10 was more effective than idebenone in recovering respiration and improving survival rates after rotenone treatment.", "population_specificity": "Cells with complex I or CoQ deficiencies and zebrafish embryos treated with rotenone.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:39.385848+00:00"}
{"study_id": 20210, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the synergistic neuroprotective effect of idebenone and rasagiline against retinal ischemia-reperfusion (RIR) injury.", "results_summary": "The combination of idebenone and rasagiline significantly restored retinal thickness and retinal ganglion cells, reduced apoptosis, and increased brain-derived neurotrophic factor expression. The treatment also modulated Lin28A/B and let-7 microRNA pathways, demonstrating a synergistic neuroprotective effect.", "population_specificity": "Retinal ischemia-reperfusion (RIR) injury model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Immediate administration post-RIR model establishment (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:39.490288+00:00"}
{"study_id": 20211, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review strategies to improve Idebenone's bioavailability and effectiveness in treating neurodegenerative diseases and skin disorders.", "results_summary": "The study highlights Idebenone's potential therapeutic applications but notes its poor bioavailability due to unfavorable physicochemical properties. Various delivery systems and chemical modifications were explored to enhance its effectiveness.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:39.745986+00:00"}
{"study_id": 20212, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to determine whether Idebenone (IDB) influences bone marrow-derived mesenchymal stem cells (BMSCs) in terms of proliferation, cloning, migration, senescence, and apoptosis.", "results_summary": "IDB at suitable concentrations enhanced BMSC cloning capacity, promoted proliferation, delayed senescence, and inhibited apoptosis and migration. It also modulated the expression of various proteins linked to cell survival, proliferation, and differentiation.", "population_specificity": "Bone marrow-derived mesenchymal stem cells (BMSCs) from Sprague-Dawley rats.", "effective_dosage": "Not specified (only \"suitable concentrations\" mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:42.487288+00:00"}
{"study_id": 20216, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to improve Idebenone's efficacy by synthesizing ester derivatives (IDETRL and IDELIP) and loading them into solid lipid nanoparticles (SLN) to enhance water solubility and prolong antioxidant activity.", "results_summary": "IDETRL and IDELIP showed greater antioxidant activity than IDE, and encapsulation into SLN prolonged their antioxidant effects, suggesting a potential strategy to enhance IDE's therapeutic efficacy.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:42.942414+00:00"}
{"study_id": 20214, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether idebenone could reduce the risk of DMD patients falling below clinically meaningful thresholds of forced vital capacity percent of predicted (FVC% p).", "results_summary": "Idebenone treatment showed a consistent reduction in the loss of pulmonary function compared to placebo, with fewer patients declining below critical FVC% p thresholds (50%, 40%, 30%). The treatment group also had fewer patients experiencing a 10% or greater decline in FVC and FVC% p.", "population_specificity": "Duchenne muscular dystrophy (DMD) patients aged 10-18 years not using glucocorticoids.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:44.256195+00:00"}
{"study_id": 20215, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how idebenone affects mitochondrial biogenesis and neural stem cell fate decisions during different stages of human induced pluripotent stem cell (hiPSC) neural differentiation.", "results_summary": "Idebenone significantly stimulated mitochondrial biogenesis only at the early neural progenitor (eNP) stage, enhancing cell viability and increasing total cell number. It also influenced neural stem cell fate decisions, up-regulating neuronal and astrocytic markers at the eNP stage while promoting astrocyte differentiation at other stages.", "population_specificity": "Human induced pluripotent stem cells (hiPSCs) at neural stem cell (NSC), early neural progenitor (eNP), and advanced neural progenitor (NP) stages.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:44.587579+00:00"}
{"study_id": 20217, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate a method for analyzing idebenone in a pediatric formulation, focusing on discriminating its two redox states.", "results_summary": "The study successfully developed a reliable micellar electrokinetic chromatography method for idebenone analysis, demonstrating high selectivity, linearity, precision, and accuracy. The method was validated and applied to a pediatric formulation.", "population_specificity": "Pediatric formulation (specific population not detailed beyond this).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:46.714935+00:00"}
{"study_id": 20220, "supplement_id": 1221, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical benefits of Idebenone as a treatment for Leber's hereditary optic neuropathy (LHON).", "results_summary": "Idebenone was found to improve energy supply and functional recovery of retinal ganglion cells during the acute stage of LHON, preventing further vision loss and promoting vision recovery. Early treatment initiation was associated with better therapeutic outcomes.", "population_specificity": "Patients with Leber's hereditary optic neuropathy (LHON).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:47.659622+00:00"}
{"study_id": 20219, "supplement_id": 1221, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether idebenone (900 mg/day) could reduce the loss of respiratory function and bronchopulmonary complications in DMD patients not taking glucocorticoid steroids.", "results_summary": "Idebenone significantly reduced respiratory function loss and lowered the risk of bronchopulmonary adverse events compared to placebo, with fewer antibiotic use episodes and shorter treatment durations in the idebenone group.", "population_specificity": "Duchenne muscular dystrophy (DMD) patients aged 10-18 years, not taking glucocorticoid steroids.", "effective_dosage": "900 mg/day", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:47.860355+00:00"}
{"study_id": 20218, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of idebenone on inspiratory muscle function in Duchenne muscular dystrophy (DMD) patients not taking glucocorticoid steroids.", "results_summary": "Idebenone stabilized maximum inspiratory flow (V'I,max(FVC)) and improved inspiratory flow reserve (IFR) compared to placebo, which showed significant decline in these measures. The between-group differences were statistically significant, suggesting preservation of inspiratory muscle function with idebenone.", "population_specificity": "10-18 year-old DMD patients not taking glucocorticoid steroids.", "effective_dosage": "Not specified in the abstract.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:48.333695+00:00"}
{"study_id": 20223, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether idebenone could prevent oxLDL-induced endothelial dysfunction and its underlying mechanisms in atherosclerosis.", "results_summary": "Idebenone significantly prevented oxLDL-induced endothelial dysfunction by inhibiting oxidative damage, suppressing apoptosis-related proteins, attenuating lipid peroxidation, promoting SOD activity, and improving mitochondrial function via specific signaling pathways.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) exposed to oxLDL.", "effective_dosage": "Suitable concentrations (specific dosage not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:50.863274+00:00"}
{"study_id": 20222, "supplement_id": 1221, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Idebenone in treating visual impairment in adolescents and adults with Leber's hereditary optic neuropathy (LHON).", "results_summary": "The study found that oral Idebenone at 900 mg/day for 24 weeks had persistent beneficial effects in preventing further vision loss and promoting vision recovery in LHON patients compared to the natural disease course. The mechanism involves restoring cellular energy production and reactivating retinal ganglion cells.", "population_specificity": "Adolescents and adults with Leber's hereditary optic neuropathy (LHON).", "effective_dosage": "900 mg/day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:51.059705+00:00"}
{"study_id": 21214, "supplement_id": 1222, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether nonexercise activity thermogenesis reduces postprandial triglyceride concentrations and increases fat oxidation the following day.", "results_summary": "The study found that nonexercise activity significantly lowered postprandial triglyceride levels (both total and incremental AUC) and increased fat oxidation compared to sedentary conditions.", "population_specificity": "Ten healthy males", "effective_dosage": "Not specified", "study_duration": "Two trials separated by at least 7 days, with measurements taken the day after each intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:52.001212+00:00"}
{"study_id": 21213, "supplement_id": 1222, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether non-exercise activity (NEA) positively affects mood in patients with eating disorders (EDs) and healthy controls (HCs), and whether pathological exercise (PE) moderates this effect.", "results_summary": "NEA increased valence and energetic arousal in both ED patients and HCs, with stronger effects on energetic arousal in HCs. The benefits of NEA were moderated by PE levels, with lower PE associated with stronger NEA effects on energetic arousal.", "population_specificity": "29 patients with eating disorders (EDs) and 35 healthy controls (HCs).", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:54.266403+00:00"}
{"study_id": 21215, "supplement_id": 1222, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether high-fat diet (HFD) reduces spontaneous physical activity (SPA) and non-exercise activity thermogenesis (NEAT), and if DREADD-mediated activation of orexin neurons could counteract this effect.", "results_summary": "HFD consumption reduced SPA and NEAT while increasing inactivity post-meal. DREADD activation of orexin neurons restored NEAT to control levels, suggesting a potential intervention to mitigate HFD-induced inactivity.", "population_specificity": "Orexin-cre male mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:54.973626+00:00"}
{"study_id": 21216, "supplement_id": 1222, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to differentiate the within-subject effects of exercise versus nonexercise activity (NEA) on mood dimensions in everyday life.", "results_summary": "NEA increased energetic arousal and decreased calmness, with a nonsignificant tendency to increase valence. The effects were consistent across different time intervals for NEA measurement.", "population_specificity": "106 adults", "effective_dosage": "Not specified (parameterized as 15-min episodes of physical activity intensity)", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:55.531926+00:00"}
{"study_id": 19544, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anticancer properties of Myo-inositol on the DU-145 prostate cancer cell line, focusing on cell viability and proteomic changes.", "results_summary": "Myo-inositol significantly reduced DU-145 cell viability with an IC50 of 0.06 mg/ml and altered protein expression, particularly affecting proteins related to apoptosis, stress response, and tumor suppression pathways.", "population_specificity": "DU-145 prostate cancer cell line", "effective_dosage": "0.06 mg/ml (IC50)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:56.412523+00:00"}
{"study_id": 21217, "supplement_id": 1222, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of acute bouts of moderate- and high-intensity walking exercise on nonexercise activity thermogenesis (NEAT) in overweight and obese adults.", "results_summary": "Neither moderate- nor high-intensity walking exercise altered NEAT on the exercise day or the first two post-exercise days. However, NEAT increased significantly (25-33%) on the third day after high-intensity exercise compared to pre-exercise levels.", "population_specificity": "Overweight and obese adults", "effective_dosage": "Moderate-intensity: 60 min at 6 km/h; High-intensity: 60 min alternating between 6 km/h at 10% grade and 0% grade every 5 min", "study_duration": "Single bout per session, with assessments over 7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:57.595487+00:00"}
{"study_id": 19546, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic efficacy of selenium alone versus a combination of myo-inositol and selenium (MI + Se) in restoring euthyroid state in patients with autoimmune thyroiditis (AIT).", "results_summary": "The combination of MI + Se significantly reduced TSH and TgAb levels compared to selenium alone, but showed non-significant reductions in TPOAb, T3, and T4 levels.", "population_specificity": "Patients with autoimmune thyroiditis (AIT).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:58.893348+00:00"}
{"study_id": 19545, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-Pinitol (DPIN) could reverse Alzheimer's disease-like progression in 5\u00d7FAD mice by addressing multiple pathological processes.", "results_summary": "DPIN improved cognition, reduced A\u03b2 and hyperphosphorylated tau levels, enhanced insulin pathway function, and restored gut barrier integrity and microbiota balance in 5\u00d7FAD mice.", "population_specificity": "5\u00d7FAD mice (a model for Alzheimer's disease).", "effective_dosage": "200 mg/kg/day", "study_duration": "Chronic administration (specific duration not stated in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:59.085873+00:00"}
{"study_id": 19547, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the antiepileptogenic effects of myo-inositol, scyllo-inositol, and D-chiro-inositol, their protein interactions, and their impact on seizure frequency and cognitive deficits in a kainic acid-induced epilepsy model.", "results_summary": "The study found that all three inositol isomers significantly reduced seizure frequency and duration, mitigated cognitive deficits, and interacted with specific proteins involved in epileptogenesis, with effects persisting for weeks post-treatment.", "population_specificity": "Rats with kainic acid-induced status epilepticus.", "effective_dosage": "Not specified.", "study_duration": "28 days of treatment, followed by 8 weeks of monitoring.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:01.609552+00:00"}
{"study_id": 19548, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of Myo-inositol supplements on semen quality and in vitro fertilization (IVF) outcomes, focusing on sperm parameters and testosterone levels in men with fertility issues.", "results_summary": "Myo-inositol treatment significantly improved total and progressive sperm motility, testosterone levels, and reduced spermatozoa with DNA fragmentation. The study supports its potential benefits for improving male fertility parameters.", "population_specificity": "Men with Oligo-astheno-teratozoospermia (OAT) or other fertility issues.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:02.558613+00:00"}
{"study_id": 19549, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of inositol (MYO and DCI) in oocyte maturation, ovulation restoration, androgen regulation, and gestational diabetes management.", "results_summary": "Inositol improves oocyte quality, regulates androgen synthesis, and may counteract gestational diabetes by modulating insulin signaling. It also enhances FSH signaling, increasing high-quality embryos in poor responders.", "population_specificity": "Women with PCOS and poor responders in fertility treatments, as well as pregnant women at risk of gestational diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:03.349408+00:00"}
{"study_id": 19550, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of IMPA1-derived inositol in maintaining prostate cancer stem cells (PCSCs) and its contribution to castration-resistant prostate cancer (CRPC) progression and androgen ablation therapy (ABT) resistance.", "results_summary": "The study found that IMPA1-derived inositol is crucial for maintaining PCSCs, promoting CRPC progression, and ABT resistance by activating IMPDH2. Targeting the IMPA1/inositol/IMPDH2 axis reduced CRPC and overcame ABT resistance in multiple models.", "population_specificity": "Prostate cancer stem cells (PCSCs), TRAMP mice, and human prostate cancer samples.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:04.299980+00:00"}
{"study_id": 19551, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of myo-inositol (MI) and D-chiro-inositol (DCI) in modulating steroidogenic gene expression and hormone secretion in androgen-rich environments of adult granulosa cell tumors (AGCTs).", "results_summary": "MI and DCI reduced StAR and CYP11A1 expression in KGN cells, with DCI alone and combined with MI also reducing CYP11A1 mRNA and E2 secretion in DHT-stimulated cells, suggesting an antiestrogenic effect of DCI in AGCTs.", "population_specificity": "In vitro models of healthy (HGrC1) and cancerous (KGN) granulosa cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:06.059508+00:00"}
{"study_id": 19553, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of inositol polyphosphate multikinase (IPMK) in activating HDAC1 and HDAC3 and its implications for intestinal barrier function.", "results_summary": "The study found that IPMK is essential for HDAC1/3 activation, and its disruption upregulates MMP genes, worsening intestinal permeability. Treatment with inositol hexaphosphate (InsP6) rescued these defects in IPMK KO cells.", "population_specificity": "Cell lines and mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:06.813482+00:00"}
{"study_id": 19552, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of myo-inositol-1-phosphate synthase (MIPS) genes in the infection process of Rhizoctonia solani in tomato plants and how myo-inositol influences disease severity.", "results_summary": "Silencing host (SlMIPS1) or pathogen (Rs_MIPS) MIPS genes prevented disease, while exogenous myo-inositol spray enhanced disease severity. SlMIPS1 upregulation altered sugar availability and suppressed salicylic acid-mediated defense, promoting infection, whereas its silencing induced defense mechanisms.", "population_specificity": "Tomato plants infected with Rhizoctonia solani.", "effective_dosage": "Not specified (exogenous spray used, but exact dosage not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:08.512345+00:00"}
{"study_id": 19554, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Intermedin (IMD) alleviates diabetic cardiomyopathy (DCM) by regulating CPT-1\u03b2 via CRLR/RAMP receptor complexes and PI3K/Akt signaling.", "results_summary": "IMD mitigated cardiac hypertrophy, fibrosis, dysfunction, and lipid accumulation in DCM models by up-regulating CPT-1\u03b2 and acetyl-CoA content, with these effects blocked by CPT-1\u03b2 knockdown or PI3K/Akt inhibition.", "population_specificity": "Diabetic cardiomyopathy rat and mouse models, and neonatal rat cardiomyocytes treated with palmitic acid.", "effective_dosage": "Not specified", "study_duration": "12 weeks for rats (fructose water), 16 weeks for mice (high-fat diet).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:08.546736+00:00"}
{"study_id": 19556, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of combined metformin and inositol versus metformin alone in treating PCOS symptoms.", "results_summary": "Combination therapy significantly improved menstrual cycle regularity, reduced hirsutism (modified Ferriman-Gallwey score), and lowered LH/FSH ratios compared to metformin alone. No significant differences were found for acne, BMI, fasting blood glucose, or HOMA-IR.", "population_specificity": "Women with PCOS", "effective_dosage": "Not available", "study_duration": "3 to 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.395221+00:00"}
{"study_id": 19555, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the dual role of IP6 (inositol hexaphosphate) as both an antinutrient and a beneficial compound with potential anti-inflammatory, antibacterial, anticancer, and bone health effects.", "results_summary": "The study found that IP6 has beneficial effects on multiple biological processes, including inhibiting pathological calcification, but raised concerns about its potential to inhibit physiological bone mineralization. However, current evidence suggests IP6 may contribute to bone health rather than inhibit bone formation.", "population_specificity": "Mammalian cells, including human cells (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.993201+00:00"}
{"study_id": 19558, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of inositol polyphosphate multikinase (IPMK) in whole-body metabolism by examining the effects of skeletal muscle-specific IPMK deletion in mice.", "results_summary": "Mice with skeletal muscle-specific IPMK deletion showed increased body weight, disrupted glucose tolerance, reduced exercise tolerance, and increased triglyceride accumulation in muscle. IPMK loss also led to reduced beta-oxidation and impaired insulin response in muscle cells.", "population_specificity": "Genetically modified mice with skeletal muscle-specific IPMK deletion.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.281650+00:00"}
{"study_id": 19557, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential diagnostic and therapeutic applications of Myo-inositol (MI) in thyroid diseases, particularly thyroid cancer (TC), hypothyroidism, and autoimmune thyroiditis.", "results_summary": "The abstract highlights MI's role as a metabolic biomarker for thyroid tumors and its ability to modulate cellular pathways involved in TC, but notes limited research in TC specifically, calling for further studies.", "population_specificity": "Patients with thyroid diseases, including thyroid cancer, hypothyroidism, and autoimmune thyroiditis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.502867+00:00"}
{"study_id": 19559, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the efficacy of myo-inositol supplementation in improving metabolic status for women with gestational diabetes.", "results_summary": "Myo-inositol supplementation significantly reduced the need for insulin treatment and improved insulin resistance (HOMA-IR) but had no significant impact on birth weight, cesarean section rates, or NICU admission needs.", "population_specificity": "Pregnant women diagnosed with gestational diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:13.484017+00:00"}
{"study_id": 19561, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of myo-inositol on oocyte and embryo quality in women undergoing assisted reproduction.", "results_summary": "The study found that myo-inositol increased the number of retrieved oocytes but showed no significant improvement in oocyte quality among poor ovarian responders, miscarriage rates, or clinical pregnancy rates.", "population_specificity": "Women undergoing assisted reproduction, including poor ovarian responders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:13.995069+00:00"}
{"study_id": 19563, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify which components of a combined supplement (including myo-inositol) contributed to reduced postpartum blood loss, previously observed in the NiPPeR trial.", "results_summary": "Higher myo-inositol concentrations in early pregnancy were associated with reduced postpartum blood loss, accounting for 84.3% of the intervention's effect. No examined vitamins showed a similar association.", "population_specificity": "583 women in preconception and pregnancy stages.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Supplementation administered preconception and during pregnancy (early and late stages).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:16.547748+00:00"}
{"study_id": 19562, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether myo-Inositol and D-Chiro-Inositol (40:1 ratio) could modulate steroidogenic activity and gene expression in ovarian cells to rescue PCOS features in a murine model.", "results_summary": "The study found that myo-Inositol and D-Chiro-Inositol (40:1 ratio) upregulated aromatase (Cyp19a1) and FSHR levels while reducing androgen excess, effectively rescuing PCOS features in treated mice. These changes were reflected in serum hormone levels.", "population_specificity": "CD1 mice with experimentally induced PCOS via continuous light exposure.", "effective_dosage": "Pharmacological and physiological concentrations (specific amounts not detailed).", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:17.578122+00:00"}
{"study_id": 19565, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of acarbose plus myo-inositol versus acarbose plus metformin in alleviating metabolic and endocrinologic complications in women with PCOS.", "results_summary": "The acarbose plus myo-inositol group showed significant reductions in fasting insulin, HOMA-IR, triglycerides, and LDL, along with increased serum progesterone, indicating improved metabolic and hormonal outcomes. No changes in BMI, total cholesterol, or VLDL were observed in any group.", "population_specificity": "168 women with PCOS attending a gynecology clinic in Chengalpattu, India.", "effective_dosage": "1000 mg myo-inositol twice daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:20.184552+00:00"}
{"study_id": 19568, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of ZmWRKY30 in regulating drought stress responses in maize, including its impact on myo-inositol metabolism.", "results_summary": "The study found that ZmWRKY30 overexpression enhanced drought tolerance in Arabidopsis, while its knockout reduced myo-inositol content in maize leaves under drought stress, suggesting a positive regulatory role in drought response.", "population_specificity": "Maize (Zea mays L.) and Arabidopsis thaliana (model plant).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.167588+00:00"}
{"study_id": 19567, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if myo-inositol trispyrophosphate (ITPP) could relieve pulmonary vasculopathy and right ventricular hypoxia, thereby preventing RV failure and mortality in a rat model of monocrotaline-induced pulmonary hypertension.", "results_summary": "ITPP reduced PH-related mortality and significantly relieved intramyocardial RV hypoxia, improving RV function and reducing wall stress, though it did not affect pulmonary vascular resistance or RV capillary density.", "population_specificity": "Rats with monocrotaline-induced pulmonary hypertension.", "effective_dosage": "Not specified", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.585667+00:00"}
{"study_id": 19566, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether myo-inositol (MI) and corn steep liquor (CSL) could improve growth and resistance to low-temperature stress in cucumber and tomato seedlings.", "results_summary": "The study found that MI and CSL treatments enhanced photosynthetic pigment levels, reduced malondialdehyde (MDA) and electrolyte leakage (REP), and improved gene expression related to stress resistance, with the best results observed at 0.6 mL L-1 CSL combined with 72 mg L-1 MI.", "population_specificity": "Cucumber and tomato seedlings under low-temperature stress.", "effective_dosage": "72 mg L-1 MI combined with 0.6 mL L-1 CSL.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.607308+00:00"}
{"study_id": 19564, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to examine the effect of Myo-inositol (MI) on zebrafish embryos' locomotor activity and its potential anxiolytic activity in zebrafish larvae.", "results_summary": "MI increased burst activity in embryos at 40 mg/mL but slightly decreased it at 10 mg/mL. MI had no impact on stress reduction (thigmotaxis index) in zebrafish larvae.", "population_specificity": "Zebrafish embryos and larvae", "effective_dosage": "5, 10, 20, and 40 mg/mL", "study_duration": "1-day post fertilization for embryos, 5-day-old larvae for behavior testing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.997451+00:00"}
{"study_id": 19569, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential roles of gene alternative splicing and lncRNAs in liver glucose and lipid metabolism in diabetes and assess the effects of myo-inositol treatment.", "results_summary": "Myo-inositol alleviated insulin resistance, lipid metabolism disorders, and hepatic steatosis in diabetic mice, with transcriptome analysis revealing differential splicing events and lncRNAs related to these effects.", "population_specificity": "Diabetic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:22.241235+00:00"}
{"study_id": 19570, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the protective effects of Myo-inositol (MI) against hyperglycemia and dyslipidemia in a type 2 diabetes mellitus (T2DM) animal model (db/db mice).", "results_summary": "MI effectively reduced plasma glucose, insulin levels, and insulin resistance in db/db mice, comparable to metformin. It also lowered plasma triglycerides and cholesterol and inhibited adipocyte differentiation in mesenchymal stem cells, though it did not control obesity.", "population_specificity": "db/db mice (a model for type 2 diabetes mellitus).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:24.694788+00:00"}
{"study_id": 19571, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of maternal myo-inositol (MI) intake on embryonic MI status and metabolism in curly tail mice, a model for neural tube defects (NTDs), and explore potential protective mechanisms.", "results_summary": "Maternal MI deficiency reduced MI levels in embryos, and embryos with cranial NTDs had lower MI content. Supplemental MI or d-chiro-inositol (DCI) altered nucleotide metabolism and folate pathways, suggesting inositol's protective effect may involve enhanced nucleotide supply during neural tube closure.", "population_specificity": "Curly tail mice genetically predisposed to NTDs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:26.702593+00:00"}
{"study_id": 19572, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of inositol pyrophosphate IP8 in regulating phosphate (Pi) homeostasis through its interaction with XPR1 and PiT1 transporters.", "results_summary": "The study found that IP8 acts as a sensor for Pi homeostatic challenges, functionalizing XPR1 to modulate Pi efflux and subsequently adjust PiT1 turnover to reset Pi uptake rates. These findings provide a model for mammalian cellular Pi homeostasis.", "population_specificity": "Mammalian cells (not specified if human or animal).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:28.072046+00:00"}
{"study_id": 19573, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the roles of SHIP1 and SHIP2 proteins in cancer and other diseases, highlighting their potential as therapeutic targets.", "results_summary": "The study found that SHIP1 acts as a tumor suppressor in myeloid leukemia, while SHIP2 functions as an oncogene in various cancers and is linked to metastasis. SHIP proteins are also implicated in inflammatory diseases, Alzheimer's, stroke, and metabolic disorders, with inhibitors and activators being developed for therapeutic use.", "population_specificity": "Not specified (review of existing research on SHIP1 and SHIP2 proteins).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:29.312488+00:00"}
{"study_id": 19574, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the anti-aging effects of ginsenosides (GS) and the role of myo-inositol (MI) in improving cardiac function and reducing DNA damage in aging mice.", "results_summary": "GS treatment improved grip strength, fatigue resistance, cognitive indices, and cardiac function in middle-aged mice. MI, upregulated by GS, was positively correlated with improved cardiac function and reduced markers of DNA damage and cellular senescence.", "population_specificity": "15-month-old mice (middle-aged)", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:29.937005+00:00"}
{"study_id": 19575, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether desmethylxestospongin B (dmXeB), an IP3R inhibitor, could effectively prevent hepatic stellate cell (HSC) activation and mitigate liver fibrosis progression.", "results_summary": "dmXeB effectively inhibited HSC proliferation, migration, and fibrosis marker expression without toxicity to hepatocytes or liver organoids. It preserved HSC quiescence and altered metabolic pathways, though certain supplements restored HSC proliferation despite treatment.", "population_specificity": "Freshly isolated rat hepatic stellate cells (HSCs) and human liver organoids.", "effective_dosage": "Varying concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:30.276617+00:00"}
{"study_id": 19577, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate a new micro delivery system for myo-inositol to improve its bioavailability and therapeutic effects for polycystic ovary syndrome (PCOS).", "results_summary": "The new formulation improved myo-inositol bioavailability (1.5x higher AUC and Cmax) and ovarian follicle concentration (1.25x single dose, 1.66x after 7 days) compared to pure myo-inositol. The microparticles also showed better release profiles and reduced degradation in acidic environments.", "population_specificity": "Rat animal model (in vivo) and ex vivo porcine intestinal mucosa.", "effective_dosage": "Experimental drug loading of 14%, with Eudragit/MI weight ratio of 6 (Batch n. 3).", "study_duration": "Single administration and 7-day repeated administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:31.546316+00:00"}
{"study_id": 19576, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Actinidia arguta extract (AAE), with myo-inositol as a major component, could inhibit early atherogenic events by reducing monocyte adhesion and inflammation.", "results_summary": "AAE, containing myo-inositol, effectively reduced THP-1 monocyte adhesion, suppressed VCAM-1 expression, and inhibited key inflammatory pathways (AKT/GSK3\u03b2 and NF-\u03baB) in HUVECs and mouse aortas. Oral AAE administration also decreased macrophage infiltration and proinflammatory cytokine expression in vivo.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) and C57BL/6 mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:31.706236+00:00"}
{"study_id": 19578, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the mechanisms underlying survival and renewal in CTU-treated TNBC cells, focusing on the role of the IRE1 ER-stress pathway and its connection to inositol-requiring enzyme 1 (IRE1).", "results_summary": "The study found that CTU treatment activated pro-inflammatory signaling pathways (NF-\u03baB and XBP1) via IRE1, leading to increased self-renewal in TNBC cells. Inhibition of IRE1 reduced pro-inflammatory mediators, enhanced apoptosis, and prevented self-renewal.", "population_specificity": "Triple-negative breast cancer (TNBC) cells (MDA-MB-231) in vitro and in mouse xenograft models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:33.634959+00:00"}
{"study_id": 19579, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of inositol, particularly myo-inositol and D-chiro-inositol, in improving fertility and metabolic outcomes in women with PCOS.", "results_summary": "The study found that inositol plays a crucial role in cellular signaling, energy metabolism, glucose regulation, and fertility, suggesting it as a promising therapeutic option for PCOS. However, more research is needed to clarify its mechanisms and benefits.", "population_specificity": "Reproductive-age women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:35.115486+00:00"}
{"study_id": 19580, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to optimize the synthesis of D-chiro-inositol (DCI) in Corynebacterium glutamicum for potential therapeutic use in type II diabetes and polycystic ovary syndrome.", "results_summary": "The study identified strain DCI-7 as the optimal producer of DCI, achieving a titer of 6.96 g/L under optimized conditions (pH 8.0, 37\u00b0C, 40 g/L myo-inositol). This represents the highest reported DCI titer to date.", "population_specificity": "In vitro bacterial strain (Corynebacterium glutamicum).", "effective_dosage": "40 g/L myo-inositol.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:37.738411+00:00"}
{"study_id": 19583, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a myo-inositol, probiotics, and enriched micronutrients formulation taken during preconception and pregnancy could improve mental wellbeing compared to a standard micronutrient supplement.", "results_summary": "The study found no robust differences in mood and anxiety symptoms between the intervention and control groups, but there was a modest improvement in mental health functioning from preconception to 6-months post-delivery in the intervention group.", "population_specificity": "Women planning conception and throughout pregnancy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From preconception through pregnancy until 6-months post-delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:38.853668+00:00"}
{"study_id": 19581, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether supplementation with a specific 3.6:1 MYO:DCI ratio, along with antioxidants, vitamins, and minerals, could improve fertility outcomes in women with a history of infertility and previously failed ART undergoing IVF.", "results_summary": "The study found preliminary evidence that the supplementation regimen may contribute positively to female fertility in women undergoing IVF, particularly those with a history of primary or secondary infertility and previously failed ART.", "population_specificity": "Women with a history of infertility and previously failed ART undergoing IVF.", "effective_dosage": "Specific 3.6:1 MYO:DCI ratio, antioxidants, vitamins, and minerals (exact amounts not specified).", "study_duration": "1 to 3 months before IVF.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:39.028286+00:00"}
{"study_id": 19582, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of myo-inositol in improving the clinical, hormonal, and metabolic profiles of women with PCOS.", "results_summary": "The study found that myo-inositol significantly improved menstrual cycle regularity (68% of patients), reduced luteinizing hormone (LH) levels, LH/follicle-stimulating hormone ratio, fasting serum insulin levels, and insulin resistance. It was deemed safe with good compliance.", "population_specificity": "Women diagnosed with PCOS according to Rotterdam's criteria.", "effective_dosage": "1 g twice daily (BD).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:39.082138+00:00"}
{"study_id": 19584, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the influence of myo-inositol (MI) on insulin resistance, menstrual cycle regularity, and hyperandrogenism in women with PCOS and normal BMI.", "results_summary": "MI significantly reduced insulin resistance, improved menstrual cycle regularity in >90% of patients, and decreased androgenic hormones, with effects comparable to metformin.", "population_specificity": "Women with PCOS, normal BMI, and diagnosed insulin resistance (n=60).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:40.201644+00:00"}
{"study_id": 19585, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the roles of the enzymes Kcs1 and Vip1 in the inositol pyrophosphate pathway in Saccharomyces cerevisiae and their implications for medicine and biotechnology.", "results_summary": "The study highlights the inositol pyrophosphate pathway's regulatory roles in cellular processes like cell cycle progression, stress responses, and phosphate homeostasis, with potential therapeutic applications in higher eukaryotes. The enzymes Kcs1 and Vip1 are emphasized for their biosynthetic roles and broader implications in signaling networks.", "population_specificity": "Budding yeast (Saccharomyces cerevisiae) and higher eukaryotes (implications discussed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:40.886399+00:00"}
{"study_id": 19586, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether myo-inositol (MI) could beneficially alter long-term epigenetic and transcriptomic changes in the hippocampus following traumatic brain injury (TBI) in mice.", "results_summary": "MI treatment upregulated genes involved in immune response and inflammation, including the demethylation and increased expression of BATF2, a transcription factor linked to immune regulation. The study demonstrated that MI significantly modulates post-TBI epigenetic and transcriptomic changes in the hippocampus.", "population_specificity": "Mice subjected to controlled cortical impact (CCI) to model traumatic brain injury.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:41.560550+00:00"}
{"study_id": 19587, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Myo-inositol (MI) supplementation on oxidative stress biomarkers, liver enzymes, and obesity indices in obese patients with non-alcoholic fatty liver disease (NAFLD).", "results_summary": "MI supplementation significantly improved weight, reduced the desire to eat fatty foods, decreased serum nitric oxide levels, and improved the AST/ALT ratio, though most oxidative stress biomarkers and other parameters showed no significant between-group differences.", "population_specificity": "Obese patients newly diagnosed with NAFLD (n=48 completed the trial).", "effective_dosage": "4 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:42.828200+00:00"}
{"study_id": 19590, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether 5-InsP7, generated by inositol hexakisphosphate kinase 1 (IP6K1), regulates adiponectin biosynthesis and its potential for cardioprotection.", "results_summary": "The study found that 5-InsP7 stabilizes adiponectin interactions, driving its intracellular degradation, and that inhibiting 5-InsP7 biosynthesis increased plasma adiponectin levels and protected against myocardial ischemia-reperfusion injury.", "population_specificity": "Mice (wild-type and adiponectin knockout).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:47.072698+00:00"}
{"study_id": 19591, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effectiveness of different forms of inositol (MYO and DCI) in treating polycystic ovary syndrome (PCOS).", "results_summary": "The study found insufficient evidence to recommend DCI alone, while MYO alone showed positive results. The MYO/DCI combination was effective at a ratio of at least 40:1, with potential for further study of higher ratios (66:1 to 100:1).", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "MYO/DCI combination at a ratio of at least 40:1 (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:47.236134+00:00"}
{"study_id": 19588, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of a 40:1 ratio of myo-inositol (MI) and D-chiro-inositol (DCI) on hormonal and metabolic parameters in women with PCOS phenotype A (EMS-type I).", "results_summary": "Supplementation significantly improved metabolic (reduced BMI, HOMA-IR, insulin levels) and hormonal (decreased testosterone, LH; increased SHBG, estradiol) profiles in PCOS patients. The study demonstrated clinically meaningful outcomes despite using a lower inositol concentration than prior literature.", "population_specificity": "34 women aged 20-40 with PCOS phenotype A (EMS-type I), of whom 55.9% were overweight/obese and 50% had insulin resistance.", "effective_dosage": "2,255 mg/day (MI and DCI in a 40:1 ratio)", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:47.691333+00:00"}
{"study_id": 19589, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with myo-inositol, probiotics, and additional micronutrients preconception and during pregnancy could promote healthy postnatal weight gain and reduce obesity risk in offspring.", "results_summary": "The study found that the intervention reduced rapid weight gain and obesity incidence at 2 years, with fewer offspring in the intervention group having a BMI > 95th percentile and a lower risk of rapid weight gain in the first year and sustained weight gain over two years.", "population_specificity": "Pregnant women and their offspring, from preconception through pregnancy, with follow-up until offspring reached 2 years of age.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From preconception through pregnancy (exact duration not specified in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:48.209212+00:00"}
{"study_id": 19595, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of myoinositol or D-chiro-inositol in improving PCOS symptoms in symptomatic adolescents.", "results_summary": "The studies showed improvements in some biochemical markers, metabolic parameters, or clinical symptoms, but results were inconsistent across studies. The overall benefit of myoinositol in adolescents with PCOS remains unclear due to limited high-quality evidence.", "population_specificity": "Female adolescents (aged 12-19 years) with PCOS or PCOS-like features.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:49.587214+00:00"}
{"study_id": 19596, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the mechanism of oxaliplatin resistance in colorectal cancer and evaluate the potential of inositol hexaphosphate (IP6) to reverse this resistance.", "results_summary": "The study found that oxaliplatin resistance was linked to endoplasmic reticulum stress and cellular senescence, and IP6 effectively reversed this resistance by inhibiting diphthamide modification of eEF2 and PERK activation.", "population_specificity": "Oxaliplatin-resistant colorectal cancer models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:50.674580+00:00"}
{"study_id": 19593, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of inositol, alone or in combination with other therapies, in managing PCOS, particularly its effects on metabolic, hormonal, and reproductive outcomes.", "results_summary": "The study found potential benefits of myo-inositol or D-chiro-inositol for some metabolic measures and ovulation, but no significant effects on other outcomes. Metformin showed some advantages over inositol for waist-hip ratio and hirsutism, but evidence for other comparisons was uncertain.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) (n = 2230; 1093 intervention, 1137 control).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:50.807452+00:00"}
{"study_id": 19594, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether myo-inositol, alone or combined with corn steep liquor, could enhance salt stress resistance and growth in cabbage seedlings.", "results_summary": "The study found that myo-inositol and corn steep liquor improved plant growth, photosynthesis, and ion balance under salt stress while reducing stress markers like malondialdehyde and electrolyte leakage. The combination of 0.1 mL L-1 corn steep liquor + 288 mg L-1 myo-inositol showed the most significant positive effects.", "population_specificity": "Cabbage seedlings (Brassica rapa subsp. pekinensis) under NaCl-simulated salt stress.", "effective_dosage": "288 mg L-1 myo-inositol (combined with 0.1 mL L-1 corn steep liquor).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:51.248061+00:00"}
{"study_id": 69892, "supplement_id": 1234, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of iodine in the risk, pathogenesis, and treatment of autoimmune thyroid diseases, particularly Hashimoto's thyroiditis and Graves' disease.", "results_summary": "Chronic excess iodine intake was found to induce autoimmune thyroiditis, as highly-iodinated thyroglobulin is more immunogenic. Universal salt iodization had a similar, though transient, effect on thyroid health.", "population_specificity": "Individuals with autoimmune thyroid diseases (Hashimoto's thyroiditis and Graves' disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:58.598106+00:00"}
{"study_id": 69891, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the long-term oncologic outcomes of robotic surgery versus conventional open surgery for papillary thyroid carcinoma, focusing on dynamic risk stratification.", "results_summary": "The study found that robotic surgery had comparable long-term oncologic outcomes to open surgery based on dynamic risk stratification, despite differences in surgical extent and radioactive iodine remnant ablation rates.", "population_specificity": "Patients with classic papillary thyroid carcinoma (444 propensity score-matched pairs).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 60 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:58.712063+00:00"}
{"study_id": 69894, "supplement_id": 1234, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical efficacy and life quality outcomes of total thyroidectomy combined with radioactive iodine versus conventional total thyroidectomy in thyroid cancer patients.", "results_summary": "The study found that the combination of total thyroidectomy and radioactive iodine significantly improved overall treatment efficacy and life quality scores (physiological, psychological, and social function) compared to conventional total thyroidectomy alone, with no significant difference in recurrent laryngeal nerve injury incidence.", "population_specificity": "120 thyroid cancer patients treated at the researchers' hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:59.108567+00:00"}
{"study_id": 69889, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the technical principles, clinical interpretation, benefits, and limitations of arterial subtraction CT pulmonary angiography (CTPA) for assessing iodine distribution in pulmonary parenchyma.", "results_summary": "The study found that subtraction computed tomography (SCT) effectively maps iodine distribution in pulmonary parenchyma using motion correction and image subtraction, potentially improving pulmonary embolism detection. SCT requires only software implementation, making it more accessible than dual-energy CT.", "population_specificity": "Patients with suspicion of acute and chronic pulmonary embolism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:59.457880+00:00"}
{"study_id": 69888, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the theranostic application of radioactive iodine (I-131) in the management of differentiated thyroid cancer (DTC).", "results_summary": "The study highlights that radioactive iodine (RAI) is effective in treating residual and metastatic DTC by leveraging the sodium iodide symporter (NIS) expression in thyroid cells. The theranostic approach, combining diagnostic and therapeutic uses of RAI, has remained a cornerstone in achieving cures for most DTC patients.", "population_specificity": "Differentiated thyroid cancer (DTC) patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:59.556909+00:00"}
